Page last updated: 2024-09-28

Atypical Cluster Headache

A primary headache disorder that is characterized by severe, strictly unilateral PAIN which is orbital, supraorbital, temporal or in any combination of these sites, lasting 15-180 min. occurring 1 to 8 times a day. The attacks are associated with one or more of the following, all of which are ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial SWEATING, eyelid EDEMA, and miosis. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Synonyms(11)

Synonym
Ciliary Neuralgia
Headache, Cluster
Atypical Cluster Headache
Histamine Cephalgia
Cluster Headache
Neuralgic Migraine
Horton's Syndrome
Cluster Headache Syndrome
Horton Syndrome
Episodic Cluster Headache
Chronic Cluster Headache

Research Excerpts

Overview

ExcerptReference
"Cluster headache is characterized by severe unilateral periorbital pain."( Diamond, S, 1979)
"Cluster headache is a form of unilateral headache which, in the past, has been very resistant to treatment."( Ashenhurst, EM; Wyant, GM, 1979)
"Attacks of cluster headache are difficult to treat."( , 1991)
"Cluster headache is a syndrome of severe head and facial pain accompanied by autonomic abnormalities."( Marks, DR; Rapoport, AM, 1992)
"Cluster headaches are vascular headaches that predominantly affect males and occur frequently, with cyclic regularity."( Gabai, IJ; Spierings, EL, 1990)
"Cluster headache is an uncommon form of headache syndrome."( Joubert, J, 1988)
"59 patients with cluster headache are discussed."( Huvenaars, P; Wentges, RT, 1986)
"Cluster headaches are so unique, however, that the history alone should be adequate for diagnosis."( Green, MW, 1983)
"Attacks of cluster headache are often associated with symptoms of an autonomic nature."( Saunte, C, 1984)
"Cluster headache is a defined disorder which is often mistaken in spite of its characteristic picture."( Neu, I; Pfaffenrath, V; Prosiegel, M, 1982)
"Atypical cluster headaches are localized headaches that occur several times daily, usually without any headache-free periods."( Diamond, S; Medina, JL, 1981)
"The course of cluster headache is related to changes in serotonin and histamine levels."( Diamond, S; Fareed, J; Medina, JL, 1980)
"Cluster headache is a rare very severe disorder that is clinically well characterized with a relatively poorly understood pathophysiology."( Edvinsson, L; Goadsby, PJ, 1994)
"Cluster headache is a rare form of severe idiopathic headache characterized by unilateral short-lasting episodes of excruciating pain in association with autonomic disturbances."( Goadsby, PJ, 1994)
"Cluster headache is a rare, very severe disorder that is clinically well characterized with a relatively poorly understood pathophysiology."( Blaes, F; Fischer, C; Grauer, M; Hamann, GF; Hoffmann, KH; Strittmatter, M, 1996)
"Cluster headache is included with the shorter-lasting headaches to attempt a nosological analysis of these syndromes."( Goadsby, PJ; Lipton, RB, 1997)
"Cluster headache is a rare very severe disorder that is clinically well characterized with a relatively poorly understood pathophysiology."( Blaes, F; Fischer, C; Grauer, M; Hamann, G; Hoffmann, KH; Schimrigk, K; Strittmatter, M, 1997)
"Cluster headache is a rare but very typical disease."( Koudstaal, PJ; Ridderikhoff, J, 1997)
"Episodic cluster headache is a well-recognized entity usually starting in the second decade of life."( Kuhar, M; Neubauer, D; Ravnik, IM, 1997)
"Horton's syndrome (cluster headache) is always unilateral and is often associated with unilateral lacrimation and rhinorrhoea."( Köling, A, 1998)
"Patients with cluster headache are often treated with lithium."( Fujikawa, T; Horiguchi, J; Kagaya, A; Takebayashi, M; Yamawaki, S, 1999)
"Cluster headache is a rare, severe, clinically well-characterized disorder that occurs in both episodic and chronic forms."( Gadoth, N; Hering-Hanit, R, 2000)
"Cluster headache is a devastating disorder which needs intensive drug treatment in the cluster periods."( Flote, VG; Gilhus, NE, 2000)
"Cluster headache is a rare, clinically well-characterized disabling disorder that occurs in both episodic and chronic forms."( Gadoth, N; Hering-Hanit, R, 2001)
"Cluster headache is the most painful headache syndrome known."( Rozen, TD, 2001)
"Cluster headache is a stereotypic headache disorder marked by short-lasting bouts of severe unilateral head pain and associated autonomic symptoms."( Peres, MF; Rozen, TD, 2001)
"Cluster headache is the most severe headache syndrome known to humans."( Rozen, TD, 2002)
"Cluster headache is perhaps the most painful of the primary headache disorders."( Peres, MF; Rozen, TD; Silberstein, SD; Siow, HC; Stiles, MA; Young, WB, 2002)
"Cluster headache is a well-characterized, strictly unilateral headache with cranial autonomic features and can be classified as episodic or chronic."( McGeeney, BE, 2003)
"Cluster headache is a stereotyped form of primary headache that while common in terms of neurologic illnesses is much less common as a cause of disabling headache than migraine."( Bahra, A; Goadsby, PJ, 2004)
"Cluster headache is characterized by typical autonomic dysfunctions including facial and intracranial vascular disturbances."( Gottselig, R; Messlinger, K, 2004)
"Chronic cluster headache is one of the most disabling of all neurologic conditions."( Rozen, TD, 2004)
"Cluster headache is a primary headache syndrome that is under-diagnosed and in many instances under-treated."( Rozen, TD, 2005)
"Cluster headache is a strictly unilateral headache that occurs in association with cranial autonomic features."( Goadsby, PJ; Matharu, MS, 2004)
"Cluster headache is the third most frequent type of primary cephalgia only exceeded in frequency by tension-type headache and migraine."( Bewermeyer, H; Kuhn, J, 2006)
"Attack treatment in cluster headache is based on sumatriptan and oxygen."( Fabre, N, 2005)
"Cluster headache is marked by its circadian rhythmicity and the hypothalamus appears to have a significant influence over cluster pathogenesis."( Rozen, TD, 2005)
"Cluster headache is an uncommon yet distinctive neurovascular syndrome occurring in either episodic or chronic patterns."( Capobianco, DJ; Dodick, DW, 2006)
"Cluster headache is a form of primary headache in which attacks are rapid in onset with very severe pain."( Bussone, G; Cittadini, E; Evers, S; Goadsby, PJ; May, A; Straube, A, 2006)
"Cluster headache is a form of primary headache that features repeated attacks of excruciatingly severe headache usually occurring several times a day."( Burns, B; Goadsby, PJ; Watkins, L, 2007)
"Cluster headache is characterized by severe, strictly unilateral pain attacks lasting 15 to 180 minutes localized to orbital, temporal, and midface areas accompanied by ipsilateral autonomic features."( Balasubramaniam, R; Klasser, GD, 2007)
"By far, Cluster headache is the most frequent of these syndromes."( Rosenberg-Nordmann, M; Sprenger, T; Tölle, TR, 2007)
"Cluster headache is a condition of extremely intense unilateral pain in the ocular or temporal region."( Nissilä, M, 2009)
"Cluster headache is remarkably responsive to treatment with oxygen, and yet our understanding of its mode of action is unknown."( Akerman, S; Goadsby, PJ; Holland, PR; Lasalandra, MP, 2009)
"Cluster headache is an extremely painful syndrome that occurs more frequently in men."( Budisić, M; Demarin, V; Lovrencić-Huzjan, A; Vuković, V, 2009)
"Cluster headache is a rare yet exquisitely painful primary headache disorder occurring in either episodic or chronic patterns."( Dodick, DW; Halker, R; Vargas, B, 2010)
"Cluster headache is an uncommon, but severely painful and disabling condition, with rapid onset."( Derry, S; Law, S; Moore, RA, 2010)
"Cluster headache is a rare primary headache disorder characterized by recurrent, stereotyped short-lasting attacks of severe, unilateral head pain accompanied by autonomic symptoms."( Grosberg, BM; Lipton, RB; Robbins, MS; Vollbracht, S, 2011)
"Episodic cluster headache is a severe headache syndrome and represents a suitable disease model for the investigation of episodic pain."( Boecker, H; Pfaffenrath, V; Rüther, KV; Seifert, CL; Sprenger, T; Tölle, TR; Valet, M, 2011)
"Cluster headache is characterized by severe attacks of unilateral pain, but many patients experience symptoms more commonly associated with migraine such as persistent pain."( Marmura, MJ; Pello, SJ; Young, WB, 2010)
"Cluster headache is a neurovascular disorder characterized by attacks of severe and strictly unilateral pain presenting in and around the orbit and temporal area."( Shoji, Y, 2011)
"Cluster headache is a rare primary neurovascular headache and a severe pain condition with unilateral headache over 15-180 minutes and concomitant unilateral autonomic symptoms."( Limmroth, V; Pageler, L, 2012)
"The prevalence of cluster headache is 0."( Jensen, RH; Tfelt-Hansen, PC, 2012)
"Cluster headache is associated with structural abnormalities of the hypothalamus."( Evers, S; Frese, A; Lepper, A; Nofer, JR; Summ, O, 2013)
"Because cluster headache is usually accompanied with teeth pain and/or neck pain, some patients aren't able to consult adequate medical institutions."( Owada, K, 2013)
"Cluster headache is an uncommon,severely painful, and disabling condition, with rapid onset."( Derry, S; Law, S; Moore, RA, 2013)
"The aetiology of cluster headache is partially unknown."( Donnet, A, 2015)
"Cluster headache is classified as a primary headache by definition not caused by an underlying pathology."( De Pue, A; Lutin, B; Paemeleire, K, 2016)
"Objective Episodic cluster headache is characterized by abnormalities in tyrosine metabolism (i."( Aguggia, M; Bolner, A; Bussone, G; D'Andrea, G; Fiore, PD; Giordano, G; Gucciardi, A; Leon, A; Leone, M; Perini, F; Saracco, MG, 2017)
"Cluster headache is a primary headache disorder that can occur in children and adolescents, and is a member of the broader diagnostic group of trigeminal autonomic cephalalgias."( Goadsby, P; Mack, KJ, 2016)
"Cluster headache is a rare cause of primary headache in children."( Alfaro-Iznaola, C; Ballesteros-Garcia, MM; Cuadrado-Martin, M; Natera-de Benito, D; Rodriguez-Diaz, R; Taboas-Pereira, MA, 2016)
"Cluster headache is characterized by severe, unilateral headache attacks of orbital, supraorbital or temporal pain lasting 15-180 min accompanied by ipsilateral lacrimation, rhinorrhea and other cranial autonomic manifestations."( Cecchini, AP; Giustiniani, A; Leone, M, 2017)
"Cluster headache is a debilitating disease characterized by excruciatingly painful attacks that affects 0."( Liebler, EJ; Mwamburi, M; Tenaglia, AT, 2017)
"Cluster headache is a trigeminal autonomic cephalalgia characterised by extremely painful, strictly unilateral, short-lasting headache attacks accompanied by ipsilateral autonomic symptoms or the sense of restlessness and agitation, or both."( Hoffmann, J; May, A, 2018)
"Cluster headache is a primary headache disorder characterized by multiple episodes of intense unilateral pain with autonomic features."( Robbins, MS; Wei, J, 2018)
"Cluster headache is a primary headache syndrome grouped under the trigeminal autonomic cephalalgias."( Rozen, TD, 2018)
"Both chronic and episodic cluster headaches are debilitating disorders which are often refractory to multiple prophylactic medication regimens."( Holland, LC; Limmer, AL; Loftus, BD, 2019)
"Cluster headaches are characterized by unilateral sudden onset of intense, brief, sharp pain along the side of the face around the eye."( Fadayomi, O; Kendall, MC; Nader, A, 2019)
"Cluster headache is not optimally treated and few clinical trials are available to model therapy, especially dosing and administration."( Clark, AS; Smith, TR; Wenzel, R, 2022)
"Episodic cluster headache is more responsive to acute therapy than chronic."( Barloese, M; Jensen, RH; Lund, N; Petersen, AS, 2021)
"Cluster headache is characterized by recurrent, unilateral attacks of excruciating pain associated with ipsilateral cranial autonomic symptoms."( Brudfors, M; Cheema, S; Danno, D; Grangeon, L; Matharu, M; Nachev, P; Tso, AR, 2021)
"Cluster headache is uncommon before 10 years of age and diagnosis is difficult in the first few years of life."( Barbosa, BLF; Bastos, SNMAN; Jevoux, C; Krymchantowski, A; Krymchantowski, AG; Silva, SF; Silva-Néto, RP, 2021)
"Cluster headache is a rare, strictly unilateral, severe episodic primary headache disorder."( Goadsby, PJ; O'Daly, O; Wei, DY; Zelaya, FO, 2022)
"As cluster headache is a rare condition and purely unilateral disorder, an analysis strategy to ensure all the image data corresponded to symptomatology in the same hemisphere, without losing coherence across the group, was adopted."( Goadsby, PJ; O'Daly, O; Wei, DY; Zelaya, FO, 2022)
"Cluster headache is a relatively rare, disabling primary headache disorder with a major impact on patients' quality of life."( Aleksovska, K; Carvalho, V; Evers, S; Goadsby, PJ; Jensen, RH; Leone, M; Manzoni, GC; May, A; Pascual, J; Pozo-Rosich, P; Romoli, M, 2023)
"The management of cluster headache is similar to that of other primary headache disorders and can be broadly divided into acute and preventive treatments."( Burish, MJ; Peng, KP, 2023)
"Cluster headache is treated with acute treatments, bridge treatments, and preventive treatments."( Burish, MJ; Peng, KP, 2023)
"Treatment for cluster headache is currently based on a trial-and-error approach."( Belin, AC; Fronczek, R; Gaul, C; Jensen, RH; Lund, NLT; Meisingset, T; Petersen, AS; Steinberg, A; Tfelt-Hansen, J; Tronvik, E, 2023)

Context

ExcerptReference
"Management of cluster headache has greatly changed in recent years although most of the drugs used have not received approval for this indications."( Fabre, N, 2000)
"While cluster headache has traditionally been thought of as a vascular headache disorder, its periodicity suggests involvement of the suprachiasmatic nucleus of the hypothalamus, the biological clock."( Pringsheim, T, 2002)
"Patients with chronic cluster headache have unremitting illness that necessitates daily preventive medical treatment for years."( Burns, B; Goadsby, PJ; Watkins, L, 2007)
"Cluster headaches have always been among the most intriguing of the commonly recognized primary headache syndromes."( Spears, R; Stillman, M, 2008)
"Cluster headaches have an incidence of 1-3 per 10,000 with a 2."( Agosti, R; Granata, L; Langner, R; Niebergall, H; Sakellaris, L, 2016)

Treatment

ExcerptReference
"Fifteen patients with symptomatic cluster headache participated in a double-blind crossover trial of a combined histamine H1 and H2 antagonist treatment."( Russell, D, 1979)
"Eight patients with episodic cluster headache, five in active episode, three out of episode, were investigated as to diameters of intracranial arteries before and after nitroglycerin (NG) administration."( Greitz, D; Hannerz, J, 1992)
"Attacks of cluster headache are difficult to treat."( , 1991)
"We report a 31-year-old man with cluster headaches who developed severe, prolonged myocardial ischemia following combination therapy with ergotamine tartrate and methysergide."( Galer, BS; Lipton, RB; Newman, LC; Solomon, S; Spierings, EL, 1991)
"Medical treatment of chronic cluster headaches (cluster headaches that occur frequently without remission) can be very difficult."( Covington, EC; Hassenbusch, SJ; Kosmorsky, GS; Kunkel, RS; Pillay, PK, 1991)
"We reviewed our experience with 54 cluster headache patients (23 episodic, 31 chronic) admitted to our headache center 64 tines over the past five years and treated with repetitive intravenous dihydroergotamine (IV DHE)."( Hopkins, MM; Mather, PJ; Schulman, EA; Silberstein, SD, 1991)
"Attacks of cluster headache provoked by the administration of nitroglycerin (1 mg sublingually) or histamine (0."( Bogucki, A, 1990)
"Ten episodic cluster headache patients in their active cluster period, ten patients in remission and five control subjects were monitored for minute to minute changes in oxygen saturation (SaO2) and pulse rate before and after nitroglycerin (NTG) administration."( Kudrow, DB; Kudrow, L, 1990)
"Chronic Cluster Headache (CCH) treatment is troublesome; since there are no pain-free periods, it must be continuous."( Bussone, G; Granella, F; Leone, M; Magri, M; Manzoni, GC; Micieli, G; Nappi, G; Peccarisi, C, 1990)
"15 chronic cluster headache patients in whom pain was induced by nitroglycerin received acute intravenous treatment with a calcium entry blocker."( Boiardi, A; Bussone, G; Gemma, M; Peccarisi, C; Porta, E, 1986)
"Seven therapy-resistant patients with cluster headache (six of whom were chronic) were treated by percutaneous retro-Gasserian glycerol injections under general anesthesia."( Ekbom, K; Hardebo, JE; Lindgren, L; Nilsson, BY; Waldenlind, E, 1987)
"After treatment with cyproheptadine, the cluster headache attacks ceased, but 2 days later, before the discontinuation of the treatment, the attacks of trigeminal neuralgia reappeared."( Klimek, A, 1987)
"Our patient, who had been suffering from cluster headache for approximately 30 years, had been in haemodialysis treatment for the last ten years for chronic renal failure."( Corsini, GU; Del Zompo, M; Mulas, S; Zuddas, A, 1985)
"Twenty-one patients with cluster headaches participated in an open trial to assess the effectiveness of lithium carbonate in the acute treatment and prevention of cluster headaches."( Damasio, H; Lyon, L, 1980)
"6 patients with chronic cluster headache were treated with lithium carbonate in order to establish the individual lowest effective dose and to assess the possibility of suspending treatment after prolonged administration."( Manzoni, GC; Terzano, MG, 1980)
"The way interrupting the treatment in episodic cluster headache is proposed."( Manzoni, GC; Parma, M; Terzano, MG, 1980)
"Patients with cluster headache were treated for acute attacks with sumatriptan 6mg subcutaneously or placebo in 2 crossover trials."( McTavish, D; Plosker, GL, 1994)
"Thirty male patients with cluster headache were given 4% lidocaine solution to use intranasally as an abortive therapy."( Robbins, L, 1995)
"With verapamil cluster headache can be treated successfully, flunarizine shows less impressive clinical efficacy."( Wessely, P; Wöber-Bingöl, C, 1993)
"Eighteen cluster headache patients and five controls were studied using ultrasound duplex techniques to measure blood flow in the common carotid arteries after nitroglycerin and placebo administration."( Hannerz, J; Jogestrand, T, 1993)
"It has been suggested that treatment of cluster headache (CH) patients with topical capsaicin may desensitize sensory neurons by depleting the nerve terminals of substance P."( Arrowsmith, F; Marks, DR; Padla, D; Rapoport, A; Rosum, R; Sheftell, F; Weeks, R, 1993)
"In 75% of patients with cluster headache treated with sumatriptan 6 mg sc, relief was achieved within 15 min."( Diener, HC; Pfaffenrath, V; Schoenen, J; Steiner, TJ; Wilkinson, M, 1995)
"The spontaneous capricious course of cluster headache may give rise to some problems when treatment is being evaluated."( Ekbom, K, 1995)
"Five patients with cluster headache and 15 patients with migraine were treated."( Hauser, R; Probst, R; Welge-Lüssen, A, 1996)
"Nine patients with chronic cluster headache were studied as to end-tidal PCO2, heart rate, blood pressure, common carotid artery blood flow, vascular resistance, and intensity and duration of pain before, during, and after breathing 6% CO2 in air for 6 minutes and before and after administration of 1 mg nitroglycerin sublingually."( Hannerz, J; Jogestrand, T, 1996)
"All of the treated 14 chronic cluster headache patients completed the study."( Di Sabato, F; Giacovazzo, M; Martelletti, P; Rocco, M, 1997)
"Many cluster headache patients had not, to their knowledge, been prescribed or used the best symptomatic and prophylactic treatments for cluster headache."( Becker, WJ; Riess, CM; Robertson, M, 1998)
"Subcutaneous self-treatment of cluster headache is both highly effective and well tolerated."( Göbel, H; Heinze, A; Lindner, V; Pfaffenrath, V; Ribbat, M; Stolze, H, 1998)
"Patients with cluster headache are often treated with lithium."( Fujikawa, T; Horiguchi, J; Kagaya, A; Takebayashi, M; Yamawaki, S, 1999)
"The treatment of cluster headache patients is at present suboptimal, both regarding symptomatic and prophylactic drugs."( Flote, VG; Gilhus, NE, 2000)
"Four patients continued to treat all cluster headache attacks with the intranasal sumatriptan formula, two patients had switched to subcutaneous sumatriptan and one patient was in remission since the end of the study."( Arnold, G; Einhäupl, KM; Kinze, S; Reuter, U; Schuh-Hofer, S, 2002)
"A 36-year-old man with cluster headache refractory to trials of standard prophylactic treatment and only partially responsive to parenteral sumatriptan and inhaled oxygen was admitted to an inpatient pain unit."( Loder, E, 2002)
"The number of cluster headaches per week during the treatment and posttreatment periods, pain intensity, presence of associated symptoms, and the incidence of adverse events were assessed."( Bernstein, JE; Klapper, J; Mathew, NT; Phillips, SB; Rapoport, A; Saper, JR, 2002)
"We treated 14 cluster headache patients with greater occipital nerve block as transitional therapy (treatment initiated at the same time as preventive therapy)."( Peres, MF; Rozen, TD; Silberstein, SD; Siow, HC; Stiles, MA; Young, WB, 2002)
"Patients with chronic cluster headache completed a baseline diary for 1 month, followed by 1 month of melatonin treatment, then 1 month of placebo."( Aubé, M; Dobson, CF; Hamel, E; Magnoux, E; Pringsheim, T, 2002)
"Patients with chronic cluster headache or patients with episodic cluster headache whose headaches are uncontrolled on conventional therapy do not appear to gain therapeutically from the addition of melatonin to their usual treatment regimens."( Aubé, M; Dobson, CF; Hamel, E; Magnoux, E; Pringsheim, T, 2002)
"In episodic cluster headache early treatment onset stopped attacks within 20 days in 80%, late treatment onset was successful within ten days in 67%."( Stallmach, M, 2003)
"For the treatment of episodic cluster headache, there was complete resolution in 44 (73%) of 60 cases, partial resolution in 9 cases (13%), and failure in 7 cases (12%)."( Magnoux, E; Zlotnik, G, 2004)
"The number of cluster headache attacks was recorded during a baseline period of 6 days, and during 6 days of treatment with eletriptan 40 mg twice daily."( Vigl, M; Wessely, P; Wöber, C; Zebenholzer, K, 2004)
"The clinical management of cluster headache (CH) attacks requires a symptomatic treatment that is rapidly effective in resolving or significantly reducing symptoms."( Manzoni, GC; Torelli, P, 2004)
"This report describes four patients with cluster headache who developed gingival enlargement after initiating treatment with verapamil."( Ferrari, MD; Goadsby, PJ; Matharu, MS; van Vliet, JA, 2005)
"We report three cases with cluster headache treated with sumatriptan nasal spray."( Oda, A; Watanabe, M, 2005)
"Attack treatment in cluster headache is based on sumatriptan and oxygen."( Fabre, N, 2005)
"Chronic cluster headache remains refractory to medical therapy in at least 30% of those who suffer from this condition."( de Campos, RW; Kowacs, PA; Lange, MC; Piovesan, EJ; Werneck, LC; Zetola, VF, 2005)
"He was recently diagnosed with cluster headaches and was treated with indomethacin, prednisone, butalbital-acetaminophen-caffeine and hydrocodone without relief."( Fulton, JA; Hoffman, RS; Kahn, J; Nelson, LS, 2006)
"The authors interviewed 53 cluster headache patients who had used psilocybin or lysergic acid diethylamide (LSD) to treat their condition."( Halpern, JH; Pope, HG; Sewell, RA, 2006)
"For the acute treatment of cluster headache attacks, oxygen (100%) with a flow of at least 7 l/min over 15 min and 6 mg subcutaneous sumatriptan are drugs of first choice."( Afra, J; Evers, S; Goadsby, PJ; Leone, M; Linde, M; May, A; Sándor, PS, 2006)
"Patients with chronic cluster headache have unremitting illness that necessitates daily preventive medical treatment for years."( Burns, B; Goadsby, PJ; Watkins, L, 2007)
"Occipital nerve stimulation in cluster headache seems to offer a safe, effective treatment option that could begin a new era of neurostimulation therapy for primary headache syndromes."( Burns, B; Goadsby, PJ; Watkins, L, 2007)
"A treatment refractory chronic cluster headache patient is presented who became cluster-free on clomiphene citrate."( Rozen, T, 2008)
"A fraction of cluster headache (CH) patients face diagnostic delay, misdiagnosis, undertreatment and mismanagement."( Crevits, L; Louis, P; Paemeleire, K; Vakaet, A; Van Alboom, E; Van Zandijcke, M, 2009)
"Migraine and cluster headache (CH) are disabling syndromes that often require prophylactic treatment."( Lovell, BV; Marmura, MJ, 2010)
"Most cluster headache patients respond to oxygen therapy, but approximately 20% do not."( Backx, AP; De Ceuster, L; Haane, DY; Koehler, PJ, 2010)
"Rapid recurrence of a new cluster headache attack following oxygen treatment was named the 'rebound effect' by Kudrow (1981)."( Geerlings, RP; Haane, DY; Koehler, PJ, 2011)
"The number of cluster headache attacks (primary efficacy variable) during the three-week treatment period was reduced from 14."( Bøe, MG; Dahløf, C; Jansson, SO; Monstad, I; Salvesen, R; Stovner, LJ; Tjensvoll, AB; Tronvik, E; Wienecke, T; Zwart, JA, 2013)
"Eligible patients with episodic cluster headache will be randomized to a treatment intervention with prednisone or a placebo arm."( Burmeister, J; Diener, HC; Holle, D; Obermann, M; Ose, C; Scherag, A, 2013)
"For preventive treatment of cluster headache, calcium channel blocker (verapamil) and steroids are recommended."( Shimizu, T, 2013)
"Bipolar disorder (BD) and cluster headache (CH) are distinct conditions with important similarities such as a temporal pattern of disturbances, dysregulation of the sleep-wake cycle, and response to lithium treatment in a proportion of patients."( Alda, M; Angius, A; Ardau, R; Chillotti, C; Congiu, D; Costa, M; Deidda, A; Del Zompo, M; Niola, P; Persico, AM; Piras, IS; Pisanu, C; Severino, G; Squassina, A; Stochino, E, 2015)
"Conclusion Oxygen for the treatment of cluster headache attack is not reimbursed worldwide."( Evers, S; Rapoport, A, 2017)
"Background Treatment options for cluster headache (CH) include acute, transitional and prophylactic strategies."( Abbas, H; Diener, HC; Dresler, T; Gaul, C; Görlinger, K; Roguski, J; Totzeck, A; Weber, R, 2017)
"Patients with cluster headaches occasionally fail to respond to conventional preventive treatments."( Imai, N, 2016)
"Large international surveys of cluster headache are rare, as are examinations of treatments and side effects in older cluster headache patients."( Burish, MJ; Pearson, SM; Schor, LI; Shapiro, RE; Yan, Y, 2019)
"Refractory chronic cluster headache (CCH) is a rare but highly debilitating condition that needs new treatment options."( Ciampi de Andrade, D; Clavelou, P; Condé, S; Dallel, R; Giraud, P; Meunier, E; Moisset, X; Pereira, B; Périé, M; Picard, P, 2020)
"Pharmacological treatment of cluster headache constitutes the core of clinical management, but evidence is sparse."( Barloese, M; Jensen, RH; Lund, N; Petersen, AS, 2021)
"Episodic cluster headache is more responsive to acute therapy than chronic."( Barloese, M; Jensen, RH; Lund, N; Petersen, AS, 2021)
"Newer treatments for cluster headache include galcanezumab, neurostimulation, and somatostatin receptor agonists."( Bailey, J; Hawks, MK; Malu, OO, 2022)
"The response to cluster headache treatments has a high interindividual variation."( Barloese, M; Callesen, I; Chalmer, MA; Hansen, MB; Hansen, TF; Jensen, RH; Lund, N; Ostrowski, SR; Pedersen, AF; Pedersen, OB; Petersen, AS; Sellebjerg, F; Søborg, MK; Søndergaard, HB; Winsvold, BS; Zwart, JA, 2023)
"In, 508 cluster headache patients diagnosed according to the International Classification of Headache Disorders were genotyped and participated in a semi-structured interview to evaluate treatment response."( Barloese, M; Callesen, I; Chalmer, MA; Hansen, MB; Hansen, TF; Jensen, RH; Lund, N; Ostrowski, SR; Pedersen, AF; Pedersen, OB; Petersen, AS; Sellebjerg, F; Søborg, MK; Søndergaard, HB; Winsvold, BS; Zwart, JA, 2023)
"For the acute treatment of cluster headache attacks, there is a strong recommendation for oxygen (100%) with a flow of at least 12 L/min over 15 min and 6 mg subcutaneous sumatriptan."( Aleksovska, K; Carvalho, V; Evers, S; Goadsby, PJ; Jensen, RH; Leone, M; Manzoni, GC; May, A; Pascual, J; Pozo-Rosich, P; Romoli, M, 2023)
"The management of cluster headache is similar to that of other primary headache disorders and can be broadly divided into acute and preventive treatments."( Burish, MJ; Peng, KP, 2023)
"Treatment for cluster headache is currently based on a trial-and-error approach."( Belin, AC; Fronczek, R; Gaul, C; Jensen, RH; Lund, NLT; Meisingset, T; Petersen, AS; Steinberg, A; Tfelt-Hansen, J; Tronvik, E, 2023)

Research

Studies (940)

TimeframeStudies, This Condition (%)All Conditions %
pre-1990279 (29.68)23.3326
1990's217 (23.09)12.5806
2000's238 (25.32)18.1394
2010's151 (16.06)28.8240
2020's55 (5.85)9.53
DrugIndicatedRelationship StrengthStudiesTrials
3-hydroxykynurenine0low10
gamma-aminobutyric acid0medium93
anthranilic acid0low10
choline0low40
salicylic acid0medium41
creatine0low10
glycine0low10
glycerol0medium63
histamine0medium422
iodine0low10
kynurenine0low20
melatonin0medium243
nitrates0low40
nitrites0low40
phenol0low10
1-propanol0low10
pyridoxine0low10
quinolinic acid0low10
tryptamine0low20
vanilmandelic acid0low20
1-(3-chlorophenyl)piperazine0low10
n-methyl-3,4-methylenedioxyamphetamine0low10
homovanillic acid0low20
phenytoin0low10
hydroxyindoleacetic acid0medium61
acetaminophen0low70
acetazolamide0low10
amiodarone0low10
amitriptyline0low60
aspirin0low50
astemizole0low10
baclofen0medium41
betahistine0low10
bupivacaine0low20
caffeine0low60
verapamil0medium868
camphor, (+-)-isomer0low10
candesartan0medium11
carbamazepine0medium81
chlorothiazide0low10
chlorpheniramine0medium11
chlorpromazine0low10
cimetidine0medium32
clonazepam0low20
clonidine0medium82
cyproheptadine0low20
debrisoquin0low10
amphetamine0low10
diazepam0low10
diphenhydramine0low30
dipyridamole0low10
valproic acid0medium172
domperidone0low10
fentanyl0low10
flecainide0low10
gabapentin0medium103
guaifenesin0low10
p-hydroxyamphetamine0low20
hydroxyzine0low10
ibuprofen0low10
lidocaine0medium261
indomethacin0medium742
2-propanol0low50
ketamine0medium51
ketorolac0low10
ketotifen0medium21
kynurenic acid0low20
lamotrigine0low30
loratadine0low10
metformin0low10
methadone0low10
methoxyflurane0low10
methylphenidate0low10
metoclopramide0low60
metoprolol0low20
mianserin0low10
mirtazapine0low10
naratriptan0low50
nifedipine0medium31
nimodipine0medium41
nitroglycerin0medium313
nortriptyline0low10
octopamine0low20
omeprazole0low10
ondansetron0low10
oxybutynin0low20
pantoprazole0medium21
phenacetin0low10
phenobarbital0low10
pirenzepine0medium21
piribedil0low10
potassium chloride0low10
propofol0low10
propranolol0medium141
quipazine0low10
rizatriptan0low30
rofecoxib0low10
sumatriptan0medium15413
terfenadine0low10
tizanidine0low10
tolmetin0low10
tyramine0low140
xanthurenic acid0low10
zonisamide0low10
zopiclone0low10
prednisolone0low150
lysergic acid diethylamide0medium101
reserpine0low10
prednisone0medium305
pilocarpine0medium71
serine0low10
chloramphenicol0low10
aspartic acid0low30
ethinyl estradiol0low10
adenosine diphosphate0low20
phenylephrine0low70
levodopa0medium21
tyrosine0low30
barbituric acid0low10
histidine0low10
tryptophan0low50
arginine0low40
methylprednisolone0medium153
isosorbide dinitrate0medium21
synephrine0low20
chlorphenesin0low10
thiophenes0low20
ergotamine0medium712
methylergonovine0low10
oxazoles0medium21
thiazoles0low10
methysergide0medium461
citrulline0low10
betamethasone0medium61
cyproterone acetate0low10
hydantoins0low10
dextropropoxyphene0low10
2-bromolysergic acid diethylamide0medium21
phenylpropanolamine0low10
dihydroergotamine0medium301
echothiophate iodide0low20
psilocybin0medium103
dimenhydrinate0low10
gluconic acid0low10
copper gluconate0low10
lithium carbonate0medium333
dronabinol0low10
fluorescein-5-isothiocyanate0low10
streptomycin0low10
carbonates0low20
amitriptyline n-oxide0low10
vidarabine0low10
iodinated glycerol0low10
isometheptene0low10
tantalum0low10
cadmium0low10
gadolinium0low10
xenon0low30
magnesium sulfate0low20
chloropyramine0low10
pizotyline0low70
isosorbide-5-mononitrate0medium11
lisuride0low10
bromocriptine0low10
phenyl acetate0medium21
cetylpyridinium chloride anhydrous0low10
triamcinolone0low40
transferrin0low10
glutamic acid0low20
timolol0medium11
indoramin0low10
tramadol0low10
oxcarbazepine0low10
substance p0medium171
enkephalin, methionine0medium71
propiconazole0medium181
captopril0low10
fomesafen0medium111
cabergoline0low20
n 0437, (-)-isomer0low10
zolmitriptan0medium275
emtricitabine0low10
n-acetylaspartic acid0low20
6-sulfatoxymelatonin0medium21
n-hydroxyamphetamine0low10
cortivazol0medium21
xenon radioisotopes0low30
triazoles0low30
fluorodeoxyglucose f180low30
budipine0low10
oxazolidin-2-one0medium275
frovatriptan0medium42
eletriptan0medium21
1-hexadecyl-2-acetyl-glycero-3-phosphocholine0low10
pramipexole0low20
6-chloropenicillanic acid s-sulfoxide0low10
naproxen0low20
atropine0medium11
ramelteon0low10
cortisone0low30
lithium chloride0low20
bradykinin0medium11
oxytocin0low10
lysergamide0low10
n-formylmethionine leucyl-phenylalanine0low10
diprenorphine0low10
arachidonic acid0low10
oleic acid0low10
cocaine0medium131
mycophenolic acid0low10
melphalan0low10
enkephalin, leucine0low30
tenofovir0low10
arginine vasopressin0low20
amygdalin0low10
leuprolide0medium21
flunarizine0medium62
zucapsaicin0medium41
capsaicin0medium183
enclomiphene0low30
D-fructopyranose0medium161
lithium0medium7610
dinoprostone0medium21
vitamin k semiquinone radical0low10
leukotriene b40low10
humulene0low20
misoprostol0medium11
codeine0low10
phenylephrine hydrochloride0low50
cyproterone0low10
naloxone0medium61
oxycodone0low10
topiramate0medium171
morphine0low10
fluticasone0low10
butorphanol0low10
phosphorus0low20
pregabalin0low10
dihydroergotoxine0low10
nitrofurantoin0low10
ergoline0low30
phosphocreatine0low10
pasireotide0low10
col-1440low10
technetium tc 99m exametazime0low20
calcimycin0low10
indocyanine green0low10
acid phosphatase0low10
nociceptin0low20
gastrins0low20
beta-endorphin0low50
neuropeptide y0low10
phosphatidylcholines0low10
sodium oxybate0medium31
sodium ethylxanthate0low10
aspirin, butalbital and caffeine drug combination0low10
cardiovascular agents0low80
piperidines0low70
interleukin-80low10
vasoactive intestinal peptide0medium92
acenocoumarol0low10
warfarin0medium51
bellergal0low10
calca protein, human0low10
muramidase0low10
acyclovir0low10
cyclic gmp0low10
clozapine0low10
olanzapine0medium21
sildenafil citrate0low30
eye0low70

Protein Targets (1,648)

ProteinPotency MeasurementsInhibition MeasurementsActivation MeasurementsDrugs
Chain A, TYROSYL-DNA PHOSPHODIESTERASE250025
5-hydroxytryptamine receptor 3E010314
acetylcholinesterase320032
TDP1 protein820082
cytochrome P450 2D6520052
v-jun sarcoma virus 17 oncogene homolog (avian)310031
cytochrome P450 2D6 isoform 1280028
cellular tumor antigen p53 isoform a120012
cytochrome P450 2C19 precursor230023
cytochrome P450 2C9 precursor150015
thyroid hormone receptor beta isoform a210021
thyroid hormone receptor beta isoform 2610061
huntingtin isoform 2120012
peripheral myelin protein 22460046
cytochrome P450 3A4 isoform 1440044
muscarinic acetylcholine receptor M1420042
Gamma-aminobutyric acid receptor subunit pi4413663
Polyunsaturated fatty acid lipoxygenase ALOX15B180018
ATP-binding cassette sub-family C member 3074074
Multidrug resistance-associated protein 4074076
5-hydroxytryptamine receptor 3B010314
Bile salt export pump01010101
Beta-1 adrenergic receptor019423
5-hydroxytryptamine receptor 1A024731
5-hydroxytryptamine receptor 2C023225
D(2) dopamine receptor052662
5-hydroxytryptamine receptor 2A027330
Gamma-aminobutyric acid receptor subunit beta-14413663
Alpha-1B adrenergic receptor034438
Gamma-aminobutyric acid receptor subunit delta4413663
Gamma-aminobutyric acid receptor subunit gamma-24413865
D017018
5-hydroxytryptamine receptor 1A058766
Gamma-aminobutyric acid receptor subunit alpha-54413663
Gamma-aminobutyric acid receptor subunit alpha-34413663
Gamma-aminobutyric acid receptor subunit gamma-14413663
Gamma-aminobutyric acid receptor subunit alpha-24413663
Alpha-1D adrenergic receptor020424
5-hydroxytryptamine receptor 2A062872
5-hydroxytryptamine receptor 2C068674
Gamma-aminobutyric acid receptor subunit alpha-44413663
Gamma-aminobutyric acid receptor subunit gamma-34413663
5-hydroxytryptamine receptor 1B050252
5-hydroxytryptamine receptor 1D013316
Gamma-aminobutyric acid receptor subunit alpha-64413663
5-hydroxytryptamine receptor 1F012214
5-hydroxytryptamine receptor 5A0303
5-hydroxytryptamine receptor 2B020424
Sodium-dependent serotonin transporter039140
5-hydroxytryptamine receptor 7 012214
5-hydroxytryptamine receptor 7018119
Alpha-1B adrenergic receptor08413
Glutamate receptor ionotropic, NMDA 1 013221
5-hydroxytryptamine receptor 2B065671
Alpha-1A adrenergic receptor038543
5-hydroxytryptamine receptor 3A013519
Histamine H2 receptor265238
5-hydroxytryptamine receptor 6046150
Beta-2 adrenergic receptor0202
D(2) dopamine receptor028636
Gamma-aminobutyric acid receptor subunit alpha-14415867
Gamma-aminobutyric acid receptor subunit beta-34413663
Gamma-aminobutyric acid receptor subunit beta-24413865
Glutamate receptor ionotropic, NMDA 2A 012220
Glutamate receptor ionotropic, NMDA 2B014222
Glutamate receptor ionotropic, NMDA 2C013221
Glutamate receptor ionotropic, NMDA 2D012220
5-hydroxytryptamine receptor 3D010314
Glutamate receptor ionotropic, NMDA 3B012220
5-hydroxytryptamine receptor 3C010314
GABA theta subunit4413663
Canalicular multispecific organic anion transporter 1073073
Gamma-aminobutyric acid receptor subunit epsilon4413663
Glutamate receptor ionotropic, NMDA 3A012220
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE400040
Chain A, Cruzipain140014
regulator of G-protein signaling 4420042
Platelet-activating factor receptor0304
Inositol monophosphatase 1230023
Endothelin receptor type B0404
Sodium-dependent dopamine transporter015116
Endothelin receptor type B0404
5-hydroxytryptamine receptor 5A0707
hypoxia-inducible factor 1 alpha subunit240024
RAR-related orphan receptor gamma480048
GLI family zinc finger 3580058
AR protein860086
aldehyde dehydrogenase 1 family, member A1520052
retinoic acid nuclear receptor alpha variant 1530053
retinoid X nuclear receptor alpha420042
estrogen nuclear receptor alpha910091
peroxisome proliferator-activated receptor delta310031
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a410041
activating transcription factor 6240024
Histone H2A.x210021
heat shock protein beta-1220022
nuclear factor erythroid 2-related factor 2 isoform 1550055
lamin isoform A-delta10670067
Voltage-dependent calcium channel gamma-2 subunit300030
Glutamate receptor 2305238
Kynureninase0001
Luciferase180018
G340034
peroxisome proliferator activated receptor gamma470047
euchromatic histone-lysine N-methyltransferase 2850085
thyroid stimulating hormone receptor240024
chromobox protein homolog 1560056
parathyroid hormone/parathyroid hormone-related peptide receptor precursor8008
geminin690069
muscleblind-like protein 1 isoform 1130013
Interferon beta430043
HLA class I histocompatibility antigen, B alpha chain 340034
Guanine nucleotide-binding protein G6006
Inositol hexakisphosphate kinase 1340034
cytochrome P450 2C9, partial340034
ATAD5 protein, partial330033
GLS protein480048
Microtubule-associated protein tau330033
Smad3150015
thyroid stimulating hormone receptor380038
nuclear receptor subfamily 1, group I, member 3510051
progesterone receptor450045
EWS/FLI fusion protein450045
estrogen-related nuclear receptor alpha700070
aryl hydrocarbon receptor340034
Solute carrier family 22 member 6010011
Carbonic anhydrase 1209120
UDP-glucuronosyltransferase 1A90004
Bile salt export pump015015
Cytochrome P450 2B10102
Cytochrome P450 1A10001
Carbonic anhydrase 1020136
Carbonic anhydrase 2020338
Myoglobin0101
Cytochrome P450 1A10113
Cytochrome P450 1A207110
Prostaglandin G/H synthase 109010
Carbonic anhydrase 308117
Cytochrome P450 3A4023227
Cytochrome P450 2D6020123
Cytochrome P450 2C9 028029
Polyunsaturated fatty acid lipoxygenase ALOX150808
Sulfotransferase 1A1 0002
UDP-glucuronosyltransferase 1-60204
Arachidonate 5-lipoxygenase-activating protein0404
UDP-glucuronosyltransferase 1A1 0407
Carbonic anhydrase 4012122
Prostaglandin G/H synthase 1014014
Carbonic anhydrase 609119
Carbonic anhydrase 5A, mitochondrial09322
Prostaglandin G/H synthase 2011215
Carbonic anhydrase 708118
Nuclear receptor ROR-gamma190019
Cytochrome P450 2J2024026
Carbonic anhydrase 9010121
Carbonic anhydrase 1509015
Carbonic anhydrase 1306014
Carbonic anhydrase 1408119
Carbonic anhydrase 5B, mitochondrial08119
toxin B0001
Chain A, CARBONIC ANHYDRASE II0011
Chain A, CARBONIC ANHYDRASE II0011
Chain A, CARBONIC ANHYDRASE II0011
Chain A, Carbonic Anhydrase Ii0011
Chain A, Carbonic Anhydrase Ii0011
Chain A, Beta-lactamase240024
Chain A, Endochitinase0101
Chain A, Endochitinase0101
Chain A, Endochitinase0101
Chain A, Class Iii Chitinase Chia10101
Chain A, Carbonic anhydrase 130101
Chain A, Carbonic anhydrase II0101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase0101
Chain B, Carbonic anhydrase0101
Chain A, Carbonic anhydrase 20101
Carbonic anhydrase 0003
Carbonic anhydrase 0303
thioredoxin reductase530053
GALC protein9009
cytochrome P450 family 3 subfamily A polypeptide 4520052
glucocorticoid receptor [Homo sapiens]620062
Carbonic anhydrase 0303
Carbonic anhydrase 0303
arylsulfatase A380038
Carbonic anhydrase0303
Bloom syndrome protein isoform 1320032
survival motor neuron protein isoform d210021
Carbonic anhydrase0303
Prolyl endopeptidase0303
Carbonic anhydrase-related protein 110103
Glycogen phosphorylase, muscle form0202
Renin0404
Carbonic anhydrase 20303
Cathepsin B0101
Steryl-sulfatase0101
Polyunsaturated fatty acid 5-lipoxygenase0606
Cytochrome P450 2C80606
Cytochrome P450 2A607310
Androgen receptor013013
Translocator protein0449
Cannabinoid receptor 10516
Cytochrome P450 2B60314
Carbonic anhydrase 5A, mitochondrial0202
Adenosine receptor A1012017
Serum paraoxonase/arylesterase 10202
Dipeptidyl peptidase 40203
Endochitinase0101
Adenosine receptor A2a011118
Sodium-dependent serotonin transporter010112
Delta-type opioid receptor015321
Cytochrome P450 2C1908010
Delta-type opioid receptor013318
Mu-type opioid receptor016423
Carbonic anhydrase05010
Kappa-type opioid receptor010111
Carbonic anhydrase0101
D(1A) dopamine receptor7108
Corticosteroid 11-beta-dehydrogenase isozyme 10202
Carbonic anhydrase0309
Cholinesterase0303
Carbonic anhydrase 0404
Mu-type opioid receptor015217
Fatty-acid amide hydrolase 10505
Beta-carbonic anhydrase 10404
Carbonic anhydrase 20303
Squalene synthase0101
Neuronal acetylcholine receptor subunit alpha-707210
Carbonic anhydrase0303
Carbonic anhydrase, alpha family 0303
Carbonic anhydrase 05011
Carbonic anhydrase 30404
Carbonic anhydrase0209
Carbonic anhydrase04011
Carbonic anhydrase 0303
Sigma intracellular receptor 20202
Delta carbonic anhydrase0303
Sigma non-opioid intracellular receptor 10729
Renin0101
Carbonic anhydrase 0309
Endochitinase A10101
Multidrug resistance-associated protein 10101
Carbonic anhydrase 1306110
Carbonic anhydrase 40407
Acidic mammalian chitinase0101
Carbonic anhydrase 70101
Carbonic anhydrase 0101
Carbonic anhydrase 0101
Carbonic anhydrase 2, isoform A 0101
Chain E, Purine nucleoside phosphorylase0101
Chain A, HADH2 protein250025
Chain B, HADH2 protein250025
Chain A, ATP-DEPENDENT DNA HELICASE Q17007
Chain A, Ferritin light chain130013
Thymidine kinase 0101
phosphopantetheinyl transferase350035
hemoglobin subunit beta2002
atrial natriuretic peptide receptor 1 precursor8008
ubiquitin carboxyl-terminal hydrolase 2 isoform a140014
Solute carrier family 22 member 1 021029
Purine nucleoside phosphorylase0101
Thymidine kinase, cytosolic0002
POU domain, class 2, transcription factor 20001
Disintegrin and metalloproteinase domain-containing protein 17110011
Purine nucleoside phosphorylase0011
Solute carrier family 22 member 60609
Thymidine kinase 0101
Solute carrier family 22 member 80509
Thymidine kinase0101
Chain A, Heat Shock Protein 900011
Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE0011
Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE0011
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN0101
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN0101
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN0101
Chain A, Myosin Ie Heavy Chain0011
Chain A, Preprotein translocase secA0011
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, Phosphoribosylformylglycinamidine synthase0101
Chain A, nucleoside diphosphate kinase A0011
Chain B, nucleoside diphosphate kinase A0011
Chain D, DNA polymerase III subunit gamma0011
Chain D, DNA polymerase III subunit gamma0011
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 30011
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 30011
Chain A, Kinesin-like protein KIF110101
HPr kinase/phosphorylase0011
Mitogen-activated protein kinase kinase kinase 70011
ATP-dependent molecular chaperone HSP820001
Heat shock protein HSP 90-alpha0113
Heat shock protein HSP 90-beta0113
2-dehydropantoate 2-reductase0112
Heat shock 70 kDa protein 1A 0112
Endoplasmic reticulum chaperone BiP0011
Heat shock cognate 71 kDa protein0011
Pyruvate kinase PKM 0001
Pyruvate kinase PKLR 0001
Endoplasmin0001
Heat shock cognate 71 kDa protein0011
5'-nucleotidase0101
Mu-type opioid receptor037948
Delta-type opioid receptor024632
Kappa-type opioid receptor0271039
Endoplasmin0112
P2Y purinoceptor 20011
Phosphatidylinositol 4-kinase alpha0202
P2X purinoceptor 10011
P2Y purinoceptor 10011
P2Y purinoceptor 10011
P2X purinoceptor 10011
P2X purinoceptor 40011
P2X purinoceptor 50011
P2X purinoceptor 60011
P2X purinoceptor 30011
Heat shock protein 75 kDa, mitochondrial0101
P2Y purinoceptor 60011
Phosphatidylinositol 4-kinase type 2-beta0202
P2Y purinoceptor 110011
Phosphatidylinositol 4-kinase type 2-alpha0202
P2Y purinoceptor 120112
Sensor protein kinase WalK0101
Phosphatidylinositol 4-kinase beta0202
P2X purinoceptor 20011
SMAD family member 2190019
Fumarate hydratase190019
USP1 protein, partial410041
NFKB1 protein, partial200020
PPM1D protein7007
SMAD family member 3190019
Thrombopoietin120012
caspase 7, apoptosis-related cysteine protease140014
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)170017
estrogen receptor 2 (ER beta)290029
farnesoid X nuclear receptor360036
pregnane X nuclear receptor560056
polyprotein190019
caspase-3140014
D(1A) dopamine receptor310031
potassium voltage-gated channel subfamily H member 2 isoform d390039
mitogen-activated protein kinase 1190019
flap endonuclease 1200020
serine/threonine-protein kinase mTOR isoform 1130013
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1150015
urokinase-type plasminogen activator precursor100010
plasminogen precursor100010
urokinase plasminogen activator surface receptor precursor100010
nuclear receptor ROR-gamma isoform 1240024
lethal factor (plasmid)190019
Voltage-dependent L-type calcium channel subunit alpha-1C0606
Solute carrier organic anion transporter family member 1A40305
Voltage-dependent L-type calcium channel subunit alpha-1F015116
5-hydroxytryptamine receptor 4059059
Lysine-specific demethylase PHF20101
Thyroid hormone receptor alpha0101
Receptor tyrosine-protein kinase erbB-20606
Cellular tumor antigen p53560056
Integrin beta-372110
Tyrosine-protein kinase Fyn0808
ATP-dependent translocase ABCB1010010
Aldo-keto reductase family 1 member B1039039
Muscarinic acetylcholine receptor M2036546
Muscarinic acetylcholine receptor M4036241
ATP-dependent translocase ABCB1027242
Integrin alpha-IIb72110
Muscarinic acetylcholine receptor M5035139
Alpha-2A adrenergic receptor054661
Adenosine receptor A3019120
Thyroid hormone receptor alpha0336
Thyroid hormone receptor beta0336
Muscarinic acetylcholine receptor M1040753
Beta-3 adrenergic receptor015318
Lethal factor0101
Alpha-2B adrenergic receptor050253
Thyroid hormone receptor beta0202
Muscarinic acetylcholine receptor M3038344
ATP-dependent translocase ABCB1010011
Substance-K receptor014014
D(1A) dopamine receptor042348
D(4) dopamine receptor019224
Carnitine O-palmitoyltransferase 2, mitochondrial0101
Sodium-dependent noradrenaline transporter 047148
Histamine H2 receptor028432
Endothelin-1 receptor0415
Lysine-specific demethylase 5A0101
B2 bradykinin receptor0417
Melanocortin receptor 40606
C-8 sterol isomerase0202
Melanocortin receptor 50808
D(3) dopamine receptor054361
Sodium channel protein type 1 subunit alpha0606
Sodium channel protein type 4 subunit alpha09012
Squalene synthase0101
C-C chemokine receptor type 20404
Melanocortin receptor 30606
Carnitine O-palmitoyltransferase 1, liver isoform0101
C-C chemokine receptor type 40202
Spike glycoprotein372443
Sodium channel protein type 7 subunit alpha0404
Voltage-dependent L-type calcium channel subunit alpha-1D 015116
Sodium-dependent dopamine transporter 032133
Potassium voltage-gated channel subfamily H member 2045146
Voltage-dependent L-type calcium channel subunit alpha-1S015116
Voltage-dependent L-type calcium channel subunit alpha-1C017119
Sodium channel protein type 5 subunit alpha012012
Squalene monooxygenase0101
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase0202
Sodium channel protein type 9 subunit alpha0909
Lysine-specific demethylase 7A0101
Carnitine O-palmitoyltransferase 1, muscle isoform0101
Sodium channel protein type 2 subunit alpha0707
Ataxin-2400040
Sigma non-opioid intracellular receptor 1030131
NAD-dependent protein deacetylase sirtuin-3, mitochondrial0112
Sodium channel protein type 3 subunit alpha0808
Sodium channel protein type 11 subunit alpha0404
Histone lysine demethylase PHF80101
Sodium channel protein type 8 subunit alpha0404
Sodium channel protein type 10 subunit alpha0505
ATP-dependent phosphofructokinase380038
atrial natriuretic peptide receptor 2 precursor9009
Albumin0088
High affinity nerve growth factor receptor0123
Muscarinic acetylcholine receptor M1017121
Muscarinic acetylcholine receptor M3016120
Muscarinic acetylcholine receptor M4015119
Muscarinic acetylcholine receptor M5015119
Muscarinic acetylcholine receptor M2016121
Angiotensin-converting enzyme019020
Alpha-2C adrenergic receptor042548
D(1B) dopamine receptor0608
UDP-glucuronosyltransferase 1A40208
Alpha-1D adrenergic receptor041345
5-hydroxytryptamine receptor 60527
Histamine H1 receptor0819
5-hydroxytryptamine receptor 5A0527
5-hydroxytryptamine receptor 5B0527
Histamine H1 receptor042852
UDP-glucuronosyltransferase 1A30005
5-hydroxytryptamine receptor 3A015318
5-hydroxytryptamine receptor 7010010
Voltage-dependent N-type calcium channel subunit alpha-1B0404
5-hydroxytryptamine receptor 4 07210
Nuclear receptor subfamily 3 group C member 3 017017
5-hydroxytryptamine receptor 3B015318
Histamine H3 receptor0729
Solute carrier family 22 member 30101
Phenylethanolamine N-methyltransferase0304
Substance-P receptor0303
Cytochrome P450 2A50202
Beta-2 adrenergic receptor0439
Sigma non-opioid intracellular receptor 10617
4-aminobutyrate aminotransferase, mitochondrial0102
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN0011
Chain A, SERUM ALBUMIN0022
Chain A, SERUM ALBUMIN0022
Chain A, 2-oxoglutarate Oxygenase300030
15-lipoxygenase, partial9009
thioredoxin glutathione reductase120012
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)100010
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1160016
vitamin D3 receptor isoform VDRA320032
lethal(3)malignant brain tumor-like protein 1 isoform I4004
DNA polymerase kappa isoform 1180018
histone acetyltransferase KAT2A isoform 1230023
DNA dC->dU-editing enzyme APOBEC-3G isoform 11102
caspase-1 isoform alpha precursor4004
Fatty-acid amide hydrolase 10404
Prostaglandin G/H synthase 1 0507
Trypsin0202
Coagulation factor VII0303
60 kDa chaperonin0202
60 kDa heat shock protein, mitochondrial0202
Aromatase0303
Tissue factor0404
Fatty acid-binding protein, adipocyte0516
Nuclear receptor subfamily 4 group A member 20022
10 kDa heat shock protein, mitochondrial0202
Calmodulin 0124
Prostaglandin G/H synthase 20809
Solute carrier organic anion transporter family member 2A10002
Fatty acid-binding protein 50202
Fatty acid-binding protein 50011
Thiosulfate sulfurtransferase0202
Lanosterol 14-alpha demethylase0101
60 kDa chaperonin 0303
10 kDa chaperonin 0303
Solute carrier organic anion transporter family member 1B30405
Cytosolic phospholipase A2 gamma0202
Transient receptor potential cation channel subfamily V member 20213
Solute carrier organic anion transporter family member 1B10608
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN0022
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN0022
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN0022
alpha-galactosidase8008
DNA polymerase iota isoform a (long)250025
Nitric oxide synthase, endothelial0002
Nitric oxide synthase, brain0102
Nitric oxide synthase, brain 0102
Nitric oxide synthase, inducible0102
Nitric oxide synthase, inducible0013
Cationic amino acid transporter 30101
Vasopressin V2 receptor0326
Oxytocin receptor0336
Vasopressin V1a receptor0123
Vasopressin V1a receptor0437
Vasopressin V1b receptor0224
Vasopressin V2 receptor0011
Vasopressin V1b receptor0214
Translocator protein0102
Oxytocin receptor0202
Vasopressin V2 receptor 0213
Metabotropic glutamate receptor 60124
Excitatory amino acid transporter 40202
Glutamate transporter homolog0011
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase0101
5-hydroxytryptamine receptor 1D014321
Excitatory amino acid transporter 10304
Excitatory amino acid transporter 20304
Excitatory amino acid transporter 30304
Metabotropic glutamate receptor 10124
Metabotropic glutamate receptor 20124
Carbonic anhydrase-like protein, putative0007
Chain A, Phospholipase A2 isoform 30011
GTP-binding protein (rab7)0011
ras protein, partial0011
interleukin 89009
hypothetical protein, conserved3003
glucocerebrosidase120012
Rac1 protein0011
IDH1190019
cell division cycle 42 (GTP binding protein, 25kDa), partial0011
Prostaglandin-H2 D-isomerase0202
Prostaglandin G/H synthase 2 0405
Epidermal growth factor receptor010010
Fatty acid-binding protein, liver0606
Myeloperoxidase0404
Seed linoleate 13S-lipoxygenase-10303
Glutathione hydrolase 1 proenzyme0101
Substance-P receptor0505
Urotensin-2 receptor0101
4-aminobutyrate aminotransferase, mitochondrial0202
Ras-related protein Rab-2A0011
Rho-associated protein kinase 20202
Nicotinate phosphoribosyltransferase0303
Solute carrier family 22 member 200505
Solute carrier family 22 member 60505
glp-1 receptor, partial210021
nonstructural protein 1130013
67.9K protein190019
bromodomain adjacent to zinc finger domain 2B170017
vitamin D (1,25- dihydroxyvitamin D3) receptor380038
thyrotropin-releasing hormone receptor4004
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a240024
Caspase-78008
Spike glycoprotein0246
Replicase polyprotein 1ab0246
lysosomal alpha-glucosidase preproprotein110011
nuclear factor erythroid 2-related factor 2 isoform 2140015
caspase-38008
ubiquitin-conjugating enzyme E2 N0303
Transmembrane protease serine 20246
Polycomb protein EED0202
HLA class I histocompatibility antigen, A alpha chain 0011
Tyrosine-protein kinase Lck0303
Procathepsin L0347
Neuronal acetylcholine receptor subunit alpha-457215
Replicase polyprotein 1a0246
Replicase polyprotein 1ab0246
Replicase polyprotein 1ab0549
Replicase polyprotein 1ab0549
Neuronal acetylcholine receptor subunit beta-256214
Glycine receptor subunit alpha-10033
Substance-P receptor0415
Somatostatin receptor type 20202
Somatostatin receptor type 40202
Somatostatin receptor type 30202
Somatostatin receptor type 50202
Sigma intracellular receptor 20101
Multidrug and toxin extrusion protein 1016016
ATPase family AAA domain-containing protein 5250025
Angiotensin-converting enzyme 2 0347
Histamine H4 receptor08412
Heparanase0011
cystic fibrosis transmembrane conductance regulator0101
DNA polymerase beta6006
short transient receptor potential channel 6 isoform 10022
Muscarinic acetylcholine receptor M10113
Muscarinic acetylcholine receptor M40303
Reverse transcriptase/RNaseH 0115
Muscarinic acetylcholine receptor0326
Gamma-aminobutyric acid type B receptor subunit 20224
Gamma-aminobutyric acid type B receptor subunit 20303
Gamma-aminobutyric acid type B receptor subunit 10224
Gamma-aminobutyric acid type B receptor subunit 10202
Polyphenol oxidase 20207
Histamine H3 receptor0214
pregnane X receptor9009
nuclear receptor subfamily 1, group I, member 26006
galanin receptor type 30101
Glucocorticoid receptor016223
Glycine receptor subunit alpha-1016016
Glycine receptor subunit beta016016
Glycine receptor subunit alpha-2016016
Glycine receptor subunit alpha-3016016
ORF730033
Angiotensin-converting enzyme 0214
B2 bradykinin receptor0101
B1 bradykinin receptor0101
Olfactory receptor 51E20022
Genome polyprotein 0112
dopamine D1 receptor120012
D(3) dopamine receptor015116
Alpha-2B adrenergic receptor017522
Alpha-2C adrenergic receptor017522
Alpha-2A adrenergic receptor018523
D(1B) dopamine receptor010010
D(4) dopamine receptor011011
Alpha-synuclein4105
Glutamate receptor ionotropic, NMDA 2D0505
Glutamate receptor ionotropic, NMDA 3B0505
Glutamate receptor ionotropic, NMDA 10606
Glutamate receptor ionotropic, NMDA 2A0606
Glutamate receptor ionotropic, NMDA 2B0606
Glutamate receptor ionotropic, NMDA 2C0505
Glutamate receptor ionotropic, NMDA 3A0505
Potassium channel subfamily K member 30202
Potassium channel subfamily K member 30101
Potassium channel subfamily K member 20358
Potassium channel subfamily K member 90101
Chain A, Glycogen Phosphorylase0101
Chain A, Glycogen phosphorylase, liver form0011
Chain A, glycogen phosphorylase, liver form0011
Chain A, Glycogen phosphorylase, liver form0011
Chain A, Glycogen phosphorylase, liver form0011
Chain A, Chitinase0101
Cholinesterase0303
Glycogen phosphorylase, liver form0101
Glycogen phosphorylase, muscle form0101
Amine oxidase [flavin-containing] A0304
Acetylcholinesterase0707
Amine oxidase [flavin-containing] B0506
cAMP-specific 3',5'-cyclic phosphodiesterase 4A0303
Adenosine receptor A30101
Adenosine receptor A2a0629
Adenosine receptor A2b0102
Adenosine receptor A2b0315
Adenosine receptor A10619
Vasopressin V2 receptor0001
Serine/threonine-protein kinase mTOR0101
Adenosine receptor A2a0101
Adenosine receptor A10101
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform 0101
DNA-dependent protein kinase catalytic subunit0101
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B0101
Adenylate cyclase type 10001
Chitotriosidase-10101
Serine-protein kinase ATM0101
Serine/threonine-protein kinase ATR0101
Adenosine receptor A2b0102
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C0101
Palmitoleoyl-protein carboxylesterase NOTUM0224
Endochitinase B10101
Phosphodiesterase 0101
Broad substrate specificity ATP-binding cassette transporter ABCG20819
Guanine deaminase0101
Chain A, Putative fructose-1,6-bisphosphate aldolase120012
Chain A, JmjC domain-containing histone demethylation protein 3A130013
acid sphingomyelinase3003
endonuclease IV8008
ClpP4004
electroneutral potassium-chloride cotransporter KCC20011
TSHR protein1001
apical membrane antigen 1, AMA17007
Parkin6006
LacZ protein (plasmid)0011
XBP10202
serine-protein kinase ATM isoform a4004
hexokinase-4 isoform 13003
NPC intracellular cholesterol transporter 1 precursor5005
peripheral myelin protein 22 isoform 1180018
type-1 angiotensin II receptor0101
glucokinase regulatory protein3003
ras-related protein Rab-9A100010
serine/threonine-protein kinase PLK16006
apelin receptor0101
heat shock protein HSP 90-alpha isoform 20103
DNA damage-inducible transcript 3 protein0202
Vpr5005
streptokinase A precursor0033
neuropeptide S receptor isoform A130013
Rap guanine nucleotide exchange factor 37007
Amyloid-beta precursor protein1203
TAR DNA-binding protein 43140014
HSP40, subfamily A [Plasmodium falciparum 3D7]0001
heat shock protein 90, putative0002
Thromboxane-A synthase 0404
Type-1A angiotensin II receptor 0011
Type-1 angiotensin II receptor0315
Type-1 angiotensin II receptor0101
Type-2 angiotensin II receptor0101
Leukotriene B4 receptor 20214
transient receptor potential cation channel subfamily V member 13003
Transient receptor potential cation channel subfamily V member 10314
Lysine-specific histone demethylase 1A0101
NADH-ubiquinone oxidoreductase chain 10101
Cannabinoid receptor 10719
Cannabinoid receptor 2 0315
Potassium voltage-gated channel subfamily A member 10314
Corticotropin-releasing factor receptor 20101
Transient receptor potential cation channel subfamily V member 10326
Transient receptor potential cation channel subfamily V member 40011
Chain A, angiotensin converting enzyme0101
Chain A, angiotensin converting enzyme0101
Metallo-beta-lactamase type 20112
M-phase phosphoprotein 8210021
Prothrombin0123
Neprilysin0101
Neprilysin0101
Leukotriene A-4 hydrolase0213
EEF1AKMT4-ECE2 readthrough transcript protein0101
Leukotriene A-4 hydrolase0101
Thymidine phosphorylase0011
Endothelin-converting enzyme 10101
Succinyl-diaminopimelate desuccinylase0202
Angiotensin-converting enzyme0404
Solute carrier family 15 member 10101
Beta-lactamase TEM0101
Beta-lactamase 0203
Beta-lactamase 0202
Beta-lactamase class B VIM-2 0112
Major prion protein0022
Sodium channel protein type 1 subunit alpha0505
Sodium channel protein type 2 subunit alpha0808
Sodium channel protein type 3 subunit alpha0505
UDP-glucuronosyltransferase 2B70307
Frizzled-80011
P2X purinoceptor 40202
Caspase-20011
Dihydroxyacetone phosphate acyltransferase0001
30S ribosomal protein S60101
30S ribosomal protein S70101
50S ribosomal protein L150101
50S ribosomal protein L100101
50S ribosomal protein L110101
50S ribosomal protein L7/L120101
50S ribosomal protein L190101
50S ribosomal protein L10101
50S ribosomal protein L200101
50S ribosomal protein L270101
50S ribosomal protein L280101
50S ribosomal protein L290101
50S ribosomal protein L310101
50S ribosomal protein L31 type B0101
50S ribosomal protein L320101
50S ribosomal protein L330101
50S ribosomal protein L340101
50S ribosomal protein L350101
50S ribosomal protein L360101
30S ribosomal protein S100101
30S ribosomal protein S110101
30S ribosomal protein S120101
30S ribosomal protein S130101
30S ribosomal protein S160101
30S ribosomal protein S180101
30S ribosomal protein S190101
30S ribosomal protein S200101
30S ribosomal protein S20101
30S ribosomal protein S30101
30S ribosomal protein S40101
30S ribosomal protein S50101
30S ribosomal protein S80101
30S ribosomal protein S90101
50S ribosomal protein L130101
50S ribosomal protein L140101
50S ribosomal protein L160101
50S ribosomal protein L230101
30S ribosomal protein S150101
50S ribosomal protein L170101
50S ribosomal protein L210101
50S ribosomal protein L300101
50S ribosomal protein L60101
30S ribosomal protein S140101
30S ribosomal protein S170101
30S ribosomal protein S10101
50S ribosomal protein L180101
50S ribosomal protein L20101
50S ribosomal protein L30101
50S ribosomal protein L240101
50S ribosomal protein L40101
50S ribosomal protein L220101
50S ribosomal protein L50101
30S ribosomal protein S210101
50S ribosomal protein L250101
50S ribosomal protein L36 20101
Methionine--tRNA ligase, mitochondrial0011
transcriptional regulator ERG isoform 35005
MBT domain-containing protein 10202
Solute carrier family 22 member 109013
Lethal(3)malignant brain tumor-like protein 40202
Lethal(3)malignant brain tumor-like protein 30202
Chloroquine resistance transporter0202
Solute carrier family 22 member 207010
Lethal(3)malignant brain tumor-like protein 10202
Proteasome subunit beta type-110001
NADPH oxidase 10202
Snq2p0002
Adenylate cyclase type 1 0303
histone deacetylase 9 isoform 33003
Proteasome subunit alpha type-70001
Albumin05814
Sarcoplasmic/endoplasmic reticulum calcium ATPase 10202
Major prion protein0011
Cys-loop ligand-gated ion channel0101
Calmodulin-10314
Sphingomyelin phosphodiesterase0101
D(2) dopamine receptor0505
Proteasome subunit beta type-10001
Adenylate cyclase type 30303
Proteasome subunit alpha type-10001
Proteasome subunit alpha type-20001
Proteasome subunit alpha type-30001
Proteasome subunit alpha type-40001
Adenylate cyclase type 20303
Adenylate cyclase type 40303
Proteasome subunit beta type-80001
Proteasome subunit beta type-90001
Proteasome subunit alpha type-50001
Proteasome subunit beta type-40001
Proteasome subunit beta type-60001
Proteasome subunit beta type-50001
Trypanothione reductase0404
Histamine H1 receptor05511
Pleiotropic ABC efflux transporter of multiple drugs0204
Adenylate cyclase type 80303
Proteasome subunit beta type-100001
Proteasome subunit beta type-30001
Proteasome subunit beta type-20001
Gastrin/cholecystokinin type B receptor0202
Proteasome subunit alpha type-60012
Aldehyde oxidase 10101
Adenylate cyclase type 60303
Adenylate cyclase type 50404
Aldehyde oxidase0404
Adenylyl cyclase 7 0303
Proteasome subunit alpha-type 80001
D0505
Proteasome subunit beta type-70001
Chain A, Acetylcholinesterase0011
Chain A, Acetylcholinesterase0011
Chain A, Acetylcholinesterase0011
Chain A, Acetylcholinesterase0011
Chain A, Acetylcholinesterase0011
Chain A, Acetylcholinesterase0011
Chain A, Acetylcholinesterase0011
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein0011
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN0011
Chain A, Glycine betaine/carnitine/choline-binding protein0011
Chain A, Glycine betaine/carnitine/choline-binding protein0011
Chain A, Glycine betaine/carnitine/choline-binding protein0011
Chain A, Glycine betaine/carnitine/choline-binding protein0011
Chain A, Choline-binding protein0011
Solute carrier family 22 member 10203
Solute carrier family 22 member 209013
Solute carrier family 22 member 20202
Neuronal acetylcholine receptor subunit alpha-30326
Neuronal acetylcholine receptor subunit alpha-20326
Neuronal acetylcholine receptor subunit beta-30326
Neuronal acetylcholine receptor subunit beta-40326
Neuronal acetylcholine receptor subunit alpha-50326
Sodium- and chloride-dependent creatine transporter 10101
Choline O-acetyltransferase 0001
Neuronal acetylcholine receptor subunit alpha-60326
Neuronal acetylcholine receptor subunit alpha-90326
High affinity choline transporter 10101
Neuronal acetylcholine receptor subunit alpha-100326
cGMP-specific 3',5'-cyclic phosphodiesterase0404
Potassium-transporting ATPase alpha chain 10202
Potassium-transporting ATPase subunit beta0202
Multidrug and toxin extrusion protein 20707
Solute carrier family 22 member 110102
Solute carrier family 22 member 40101
Solute carrier family 22 member 80203
N(G),N(G)-dimethylarginine dimethylaminohydrolase 10303
General amino-acid permease GAP10001
Gamma-aminobutyric acid receptor subunit pi0808
Gamma-aminobutyric acid receptor subunit delta0808
Gamma-aminobutyric acid receptor subunit alpha-10304
Gamma-aminobutyric acid receptor subunit beta-10304
Gamma-aminobutyric acid receptor subunit alpha-20304
Gamma-aminobutyric acid receptor subunit alpha-30304
Gamma-aminobutyric acid receptor subunit alpha-1010515
Gamma-aminobutyric acid receptor subunit beta-109211
Gamma-aminobutyric acid receptor subunit gamma-209413
Gamma-aminobutyric acid receptor subunit alpha-40304
Gamma-aminobutyric acid receptor subunit gamma-20304
Gamma-aminobutyric acid receptor subunit beta-3010313
Translocator protein0202
Translocator protein0202
Cholecystokinin receptor type A1304
Gastrin/cholecystokinin type B receptor1304
Gamma-aminobutyric acid receptor subunit alpha-509413
Gamma-aminobutyric acid receptor subunit alpha-309312
Gamma-aminobutyric acid receptor subunit alpha-209312
Gamma-aminobutyric acid receptor subunit beta-209413
Gamma-aminobutyric acid receptor subunit alpha-409211
Gamma-aminobutyric acid receptor subunit epsilon0808
Gamma-aminobutyric acid receptor subunit alpha-609211
Gamma-aminobutyric acid receptor subunit gamma-10808
Gamma-aminobutyric acid receptor subunit gamma-30808
Gamma-aminobutyric acid receptor subunit theta0808
Beta-1 adrenergic receptor 0247
Alpha-1B adrenergic receptor 0033
Membrane primary amine oxidase 0101
5-hydroxytryptamine receptor 3A0224
Solute carrier family 22 member 30506
Alpha-1A adrenergic receptor0235
Alpha-2B adrenergic receptor0002
Alpha-1A adrenergic receptor013620
Alpha-2C adrenergic receptor0002
Alpha-2A adrenergic receptor0002
Alpha-2A adrenergic receptor0101
Nischarin0202
Nischarin0303
Beta-2 adrenergic receptor0506
Beta-1 adrenergic receptor07210
5-hydroxytryptamine receptor 3A0707
Beta-3 adrenergic receptor0404
5-hydroxytryptamine receptor 2C 0202
5-hydroxytryptamine receptor 2A0101
3-hydroxy-3-methylglutaryl-coenzyme A reductase 0202
D(2) dopamine receptor0101
D(3) dopamine receptor0101
D(2) dopamine receptor0202
5-hydroxytryptamine receptor 2B0101
5-hydroxytryptamine receptor 40101
Transporter0202
Cholecystokinin receptor type A0101
5-hydroxytryptamine receptor 1A0202
Transporter010213
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION0011
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION0011
Chain H, Fab M82G2, Heavy chain0011
Chain L, Fab M82G2, Light chain0011
Chain H, Fab M82g2, Heavy Chain0011
Chain L, Fab M82g2, Light Chain0011
Fatty acid-binding protein, heart0101
Muscarinic acetylcholine receptor M20112
Tryptophan 5-hydroxylase 10101
Liver carboxylesterase 10102
Lysosomal Pro-X carboxypeptidase0101
cAMP-specific 3',5'-cyclic phosphodiesterase 4B0202
cAMP-specific 3',5'-cyclic phosphodiesterase 4D0303
Leukotriene B4 receptor 10304
Sodium-dependent dopamine transporter0202
Cytochrome P450 2D10303
Cytochrome P450 2D260303
Cytochrome P450 2D30303
Kappa-type opioid receptor05310
Mu-type opioid receptor06312
Cytochrome P450 2D40303
Mas-related G-protein coupled receptor member X20055
5-hydroxytryptamine receptor 1B014418
5-hydroxytryptamine receptor 1F0415
Sex hormone-binding globulin0022
Corticosteroid-binding globulin0202
Sodium- and chloride-dependent creatine transporter 10101
Proton-coupled amino acid transporter 10404
Phosphodiesterase 0101
Multidrug resistance-associated protein 50102
cGMP-inhibited 3',5'-cyclic phosphodiesterase B0202
cGMP-inhibited 3',5'-cyclic phosphodiesterase A0202
chaperonin GroEL1001
Sodium-dependent noradrenaline transporter0101
Glycogen phosphorylase, brain form0101
Glycogen phosphorylase, muscle form0101
Sodium-dependent serotonin transporter0101
Histone-lysine N-methyltransferase SETD70202
Progesterone receptor0304
Androgen receptor0516
Gamma-aminobutyric acid 0213
Alpha-1-acid glycoprotein 10001
Gamma-aminobutyric acid receptor subunit alpha-60213
Gamma-aminobutyric acid receptor subunit gamma-20213
Gamma-aminobutyric acid receptor subunit delta0213
Gamma-aminobutyric acid receptor subunit alpha-20213
Gamma-aminobutyric acid receptor subunit alpha-30213
Gamma-aminobutyric acid receptor subunit gamma-30213
Gamma-aminobutyric acid receptor subunit beta-10213
Gamma-aminobutyric acid receptor subunit alpha-10213
Gamma-aminobutyric acid receptor subunit beta-30213
Gamma-aminobutyric acid receptor subunit alpha-50213
Gamma-aminobutyric acid receptor subunit pi0213
Sphingosine-1-phosphate lyase 10101
Gamma-aminobutyric acid receptor subunit alpha-40213
Gamma-aminobutyric acid receptor subunit theta0213
Gamma-aminobutyric acid receptor subunit gamma-10213
mu-type opioid receptor isoform MOR-10022
importin subunit beta-1 isoform 17007
fatty acid synthase0101
snurportin-17007
5-hydroxytryptamine receptor 2A0022
prostaglandin E2 receptor EP2 subtype1001
Solute carrier organic anion transporter family member 1A50003
Prostaglandin E2 receptor EP3 subtype0202
Prostaglandin E2 receptor EP4 subtype0202
Prostaglandin E2 receptor EP1 subtype0213
Prostaglandin E2 receptor EP1 subtype0202
Prostaglandin E2 receptor EP4 subtype0213
Prostaglandin F2-alpha receptor0011
Prostaglandin E2 receptor EP4 subtype0112
Prostaglandin E2 receptor EP3 subtype0213
Prostaglandin E2 receptor EP2 subtype0213
Prostacyclin receptor0213
Solute carrier family 22 member 70003
Prostaglandin E2 receptor EP2 subtype0202
Prostaglandin E2 receptor EP2 subtype0112
Solute carrier family 22 member 70001
Solute carrier organic anion transporter family member 2A10001
Solute carrier organic anion transporter family member 1B20001
Solute carrier family 22 member 70001
Histamine N-methyltransferase0001
Calcium release-activated calcium channel protein 10101
Protein orai-20101
Protein orai-30101
Histamine H3 receptor0102
Kappa-type opioid receptor07412
Chain A, Breast cancer type 1 susceptibility protein1001
RGS121001
90-kda heat shock protein beta HSP90 beta, partial0101
DNA polymerase III, partial3003
isocitrate dehydrogenase 1, partial2002
LANA0001
NPYLR7B0011
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 11001
eyes absent homolog 2 isoform a2002
histone-lysine N-methyltransferase 2A isoform 2 precursor100010
tumor susceptibility gene 101 protein2002
GTP-binding nuclear protein Ran isoform 13003
DNA dC->dU-editing enzyme APOBEC-3F isoform a2002
kelch-like ECH-associated protein 10002
cGMP-dependent 3',5'-cyclic phosphodiesterase0101
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta0101
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A0101
3',5'-cyclic-AMP phosphodiesterase 0202
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha0101
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma0101
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta0101
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'0101
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A0101
Caspase-73003
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B0101
cAMP-specific 3',5'-cyclic phosphodiesterase 4C0101
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A0101
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma0101
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C0303
Exopolyphosphatase PRUNE10101
Rap guanine nucleotide exchange factor 45005
Equilibrative nucleoside transporter 10202
Single-stranded DNA cytosine deaminase1001
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A0101
cAMP-specific 3',5'-cyclic phosphodiesterase 7B0101
Phosphodiesterase 0101
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A0101
Retinoic acid receptor RXR-alpha0033
Nuclear receptor subfamily 1 group I member 20066
Transient receptor potential cation channel subfamily A member 10012
L-lactate dehydrogenase A chain0101
Fatty acid-binding protein, liver0101
Glutamate receptor 10528
Glutamate receptor 30528
Glutamate receptor 40528
Cannabinoid receptor 10101
Cannabinoid receptor 20112
N-arachidonyl glycine receptor0011
Transient receptor potential cation channel subfamily A member 10011
Lysophosphatidylserine lipase ABHD120101
Monoglyceride lipase0101
Monoacylglycerol lipase ABHD60101
Cannabinoid receptor 20202
G-protein coupled receptor 550112
chaperonin-containing TCP-1 beta subunit homolog3003
protein AF-9 isoform a0001
Estrogen receptor0617
Opioid receptor, delta 1b 0202
Opioid receptor homologue0202
Proenkephalin-B0011
Mu-type opioid receptor0202
Adenylate cyclase 0101
Beta-2 adrenergic receptor012315
3-oxo-5-alpha-steroid 4-dehydrogenase 1 0202
Sulfotransferase 1A10214
Nuclear receptor subfamily 1 group I member 3 0101
Estrogen receptor beta0314
Aldo-keto reductase family 1 member C30505
Aldo-keto reductase family 1 member C2 0303
NAD-dependent protein deacetylase sirtuin-20202
NAD-dependent protein deacetylase sirtuin-10202
Potassium voltage-gated channel subfamily A member 50303
Potassium voltage-gated channel subfamily D member 20202
Voltage-dependent T-type calcium channel subunit alpha-1G0112
Voltage-dependent T-type calcium channel subunit alpha-1H0112
Voltage-dependent L-type calcium channel subunit beta-10101
Voltage-dependent calcium channel subunit alpha-2/delta-10101
Voltage-dependent N-type calcium channel subunit alpha-1B0101
Potassium channel subfamily K member 2 0202
Voltage-dependent T-type calcium channel subunit alpha-1I0112
Prostaglandin D2 receptor 20213
POU domain, class 2, transcription factor 10003
Voltage-dependent calcium channel subunit alpha-2/delta-10101
Gamma-aminobutyric acid receptor subunit rho-30011
Hsf1 protein0023
Histone deacetylase 30303
Sodium- and chloride-dependent GABA transporter 10303
Gamma-aminobutyric acid receptor subunit rho-10022
Gamma-aminobutyric acid receptor subunit rho-20011
Sodium- and chloride-dependent GABA transporter 10101
Sodium- and chloride-dependent taurine transporter0101
Sodium- and chloride-dependent GABA transporter 20303
Sodium- and chloride-dependent GABA transporter 30303
Sodium- and chloride-dependent GABA transporter 10202
Sodium- and chloride-dependent GABA transporter 20303
Sodium- and chloride-dependent GABA transporter 30303
Sodium- and chloride-dependent betaine transporter0303
Sodium- and chloride-dependent betaine transporter0101
Sodium- and chloride-dependent GABA transporter 30101
Histone deacetylase 40303
4-aminobutyrate aminotransferase, mitochondrial0001
Histone deacetylase 10303
Sterol O-acyltransferase 10011
Histone deacetylase 70303
Histone deacetylase 20303
Polyamine deacetylase HDAC100303
Histone deacetylase 11 0303
Histone deacetylase 80303
Platelet glycoprotein VI0011
Sodium- and chloride-dependent GABA transporter 20101
Histone deacetylase 60303
Histone deacetylase 90303
Histone deacetylase 50303
Chain A, GLUTAMATE RECEPTOR SUBUNIT 20101
Chain A, Glutamate Receptor Subunit 20101
Chain B, Glutamate Receptor Subunit 20101
Chain A, Slr1257 protein0011
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]0101
beta-2 adrenergic receptor3003
Metabotropic glutamate receptor 80202
Glutathione reductase, mitochondrial0505
Bifunctional aspartokinase/homoserine dehydrogenase 10101
ATP-citrate synthase 0101
Glutamate receptor ionotropic, kainate 10315
Metabotropic glutamate receptor 10213
Metabotropic glutamate receptor 20011
Metabotropic glutamate receptor 30011
Metabotropic glutamate receptor 40112
Metabotropic glutamate receptor 50123
Metabotropic glutamate receptor 60011
Metabotropic glutamate receptor 70011
Glutamate receptor ionotropic, kainate 10112
Metabotropic glutamate receptor 50113
Glutamate receptor ionotropic, kainate 20315
Glutamate receptor 10213
Glutamate receptor 20213
Glutamate receptor 30112
Glutamate receptor ionotropic, kainate 30304
Metabotropic glutamate receptor 80011
Glutamate receptor 40213
Excitatory amino acid transporter 3 0001
Glutamate racemase0001
Metabotropic glutamate receptor 80112
Glutamate receptor ionotropic, kainate 40304
Glutamate carboxypeptidase 20101
Glutamate receptor ionotropic, kainate 20112
Glutamate receptor ionotropic, kainate 30101
Metabotropic glutamate receptor 70113
Metabotropic glutamate receptor 30113
Metabotropic glutamate receptor 40113
Glutamate receptor ionotropic, kainate 50101
Glutamate receptor ionotropic, kainate 50304
Glutamate racemase0001
Prolyl 4-hydroxylase0101
Alpha-ketoglutarate-dependent dioxygenase FTO0101
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E0011
Sodium- and chloride-dependent glycine transporter 10101
Large neutral amino acids transporter small subunit 10505
Serine racemase0101
Sodium- and chloride-dependent glycine transporter 20101
Chain A, CARBONIC ANHYDRASE II0011
Chain A, Protein (female-specific Histamine Binding Protein 2)0011
aryl hydrocarbon receptor nuclear translocator0001
transforming acidic coiled-coil-containing protein 30001
Plasma kallikrein0005
Macrophage migration inhibitory factor0202
Histamine H3 receptor0101
Histamine N-methyltransferase 0101
Glutaminyl-peptide cyclotransferase0202
Equilibrative nucleoside transporter 40001
Histamine H4 receptor0123
Histamine H4 receptor0123
Histamine H4 receptor 0101
Carboxylic ester hydrolase 0001
Chain A, HISTIDINE-BINDING PROTEIN0011
Histidine-binding periplasmic protein0011
Glycogen synthase kinase-3 alpha0101
Glycogen synthase kinase-3 beta0213
Protein cereblon0202
Uracil nucleotide/cysteinyl leukotriene receptor0404
Acid-sensing ion channel 30101
Dihydrofolate reductase0505
Albumin0101
Fatty acid-binding protein, intestinal0213
Polyunsaturated fatty acid 5-lipoxygenase0307
Prostaglandin G/H synthase 10303
Caspase-10304
Prostaglandin G/H synthase 2 0406
Caspase-30303
Solute carrier organic anion transporter family member 1A10101
Caspase-40303
Caspase-50303
Caspase-90303
Acid-sensing ion channel 10101
Prostaglandin G/H synthase 20304
Prostaglandin G/H synthase 1 0406
Dehydrogenase/reductase SDR family member 90101
Chain A, membrane-associated prostaglandin E synthase-20101
Prostaglandin E synthase0101
Solute carrier organic anion transporter family member 2B1 0202
Cytochrome c oxidase subunit 20202
Phospholipase A2, major isoenzyme0101
Interleukin-80202
Aldo-keto reductase family 1 member B10202
Aldo-keto reductase family 1 member B10303
Aldo-keto reductase family 1 member C40202
Indoleamine 2,3-dioxygenase 10303
Multidrug resistance-associated protein 1 0315
Bifunctional epoxide hydrolase 20202
Peroxisome proliferator-activated receptor gamma0066
C-X-C chemokine receptor type 30202
Prostaglandin D2 receptor 0202
Solute carrier organic anion transporter family member 1A30103
Lactoylglutathione lyase0202
Aldo-keto reductase family 1 member C10202
Dehydrogenase/reductase SDR family member 90101
Alpha-1A adrenergic receptor0101
Acetylcholinesterase0404
Cell division control protein 42 homolog0101
Ras-related C3 botulinum toxin substrate 10101
Serine/threonine-protein kinase PAK 10101
hepatocyte nuclear factor 4-alpha isoform 20101
perilipin-50202
perilipin-10202
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a0202
Glucose-6-phosphate 1-dehydrogenase0202
6-phosphogluconate dehydrogenase, decarboxylating0202
Mitogen-activated protein kinase 130101
Aryl hydrocarbon receptor0011
Neuronal acetylcholine receptor subunit alpha-70325
Mitogen-activated protein kinase 120101
Mitogen-activated protein kinase 110101
Mitogen-activated protein kinase 140101
G protein-coupled receptor GPR350011
Vesicular glutamate transporter 30202
G-protein coupled receptor 350213
Dihydrofolate reductase0202
Potassium voltage-gated channel subfamily E member 10101
Potassium voltage-gated channel subfamily KQT member 10101
Gonadotropin-releasing hormone receptor0101
Gonadotropin-releasing hormone receptor0202
Synaptic vesicle glycoprotein 2A0202
WRN1001
integrase, partial0101
lens epithelium-derived growth factor p750101
pyruvate kinase1001
DNA polymerase eta isoform 14004
Tyrosinase0101
Solute carrier family 15 member 10101
SLC16A10 protein0003
Monocarboxylate transporter 100003
phosphoglycerate kinase1001
Potassium channel subfamily K member 180101
inositol monophosphatase 12002
Bile acid receptor0303
Sodium-dependent neutral amino acid transporter B(0)AT20101
Potassium channel subfamily K member 90101
Catechol O-methyltransferase0101
5-hydroxytryptamine receptor 1E0303
D0101
Sodium-dependent dopamine transporter0101
Cytochrome P450 1A2 0103
Cytochrome P450 2C11 0101
Ribosyldihydronicotinamide dehydrogenase [quinone]0202
Acetylcholinesterase 0101
Nociceptin receptor0112
Melatonin receptor type 1A0314
Melatonin receptor type 1C0011
Melatonin receptor type 1A0112
Melatonin receptor type 1B0314
Melatonin receptor type 1C0112
Melatonin receptor type 1B0112
Nuclear factor erythroid 2-related factor 20001
Cytochrome P450 1B10101
Carboxylic ester hydrolase 0101
Large neutral amino acids transporter small subunit 1 0101
Aldehyde oxidase 1 0101
Nuclear receptor subfamily 1 group I member 20011
Lactoperoxidase0101
5-hydroxytryptamine receptor 3B0606
Beta-1 adrenergic receptor0202
Type-2 angiotensin II receptor0303
G-protein coupled receptor 0101
Acyl-CoA desaturase 10101
Histidine decarboxylase0022
Proteinase-activated receptor 10112
Nociceptin receptor0101
Mu-type opioid receptor0101
Chain A, Inosine-5'-Monophosphate Dehydrogenase 20101
Inosine-5'-monophosphate dehydrogenase 20202
Inosine-5'-monophosphate dehydrogenase 1 0202
Inosine-5'-monophosphate dehydrogenase0102
UDP-glucuronosyltransferase 1A70001
UDP-glucuronosyltransferase 1A100001
UDP-glucuronosyltransferase 1A80003
Formyl peptide receptor-related sequence 10011
fMet-Leu-Phe receptor0224
N-formyl peptide receptor 20022
FML2_HUMAN 0011
Trace amine-associated receptor 10055
Hormone-sensitive lipase0101
Neuropeptide Y receptor type 10202
Neuropeptide Y receptor type 20202
Chain A, NAD-dependent deacetylase0101
Poly [ADP-ribose] polymerase 20101
NAD-dependent histone deacetylase SIR20101
Poly [ADP-ribose] polymerase 10101
Cytochrome P450 3A50101
NAD-dependent protein deacetylase HST20101
Protein mono-ADP-ribosyltransferase PARP150101
NAD(+) hydrolase SARM10101
NAD-dependent protein deacetylase sirtuin-60101
NAD-dependent protein deacylase sirtuin-5, mitochondrial0202
NAD-dependent protein deacetylase 0101
Neuronal acetylcholine receptor subunit alpha-40213
Acetylcholine receptor subunit alpha0213
Acetylcholine receptor subunit alpha0213
Acetylcholine receptor subunit beta0213
Acetylcholine receptor subunit gamma0213
Acetylcholine receptor subunit delta0213
Acetylcholine receptor subunit gamma0213
Neuronal acetylcholine receptor subunit alpha-40101
Acetylcholine receptor subunit beta0213
Neuronal acetylcholine receptor subunit beta-20415
Acetylcholine receptor subunit beta-like 20202
Neuronal acetylcholine receptor subunit alpha-50011
Neuronal acetylcholine receptor subunit beta-40314
Neuronal acetylcholine receptor subunit alpha-30314
Neuronal acetylcholine receptor subunit alpha-40415
Neuronal acetylcholine receptor subunit alpha-70303
Acetylcholine-binding protein0112
Acetylcholine receptor subunit epsilon0011
Neuronal acetylcholine receptor subunit beta-30112
Acetylcholine receptor subunit delta0213
Neuronal acetylcholine receptor subunit alpha-20101
Neuronal acetylcholine receptor subunit alpha-60112
Cytochrome P450 2A130336
Neuronal acetylcholine receptor subunit alpha-50202
Liver carboxylesterase B-10101
Transient receptor potential cation channel subfamily A member 10033
Neuronal acetylcholine receptor subunit beta-30202
Neuronal acetylcholine receptor subunit beta-40202
Neuronal acetylcholine receptor subunit alpha-30202
Soluble acetylcholine receptor0101
Neuronal acetylcholine receptor subunit alpha-20202
Neuronal acetylcholine receptor subunit beta-20213
Neuronal acetylcholine receptor subunit alpha-60202
Integrin beta0011
Glycoprotein IIb0011
tumor necrosis factor1001
polyunsaturated fatty acid lipoxygenase ALOX121001
Phospholipase A2, membrane associated0001
Voltage-dependent L-type calcium channel subunit alpha-1C0404
Voltage-dependent L-type calcium channel subunit alpha-1D0202
3-oxo-5-alpha-steroid 4-dehydrogenase 20101
Voltage-dependent L-type calcium channel subunit alpha-1C0101
Voltage-dependent L-type calcium channel subunit alpha-1S0202
Voltage-dependent L-type calcium channel subunit alpha-1S0101
C-terminal-binding protein 11001
Myosin light chain kinase, smooth muscle0101
Indoleamine 2,3-dioxygenase 20202
Voltage-dependent L-type calcium channel subunit alpha-1D0101
Voltage-dependent L-type calcium channel subunit alpha-1F0101
Voltage-dependent L-type calcium channel subunit beta-40101
Voltage-dependent P/Q-type calcium channel subunit alpha-1A0101
Voltage-dependent calcium channel gamma-3 subunit0101
Voltage-dependent L-type calcium channel subunit beta-30101
Voltage-dependent calcium channel subunit alpha-2/delta-10203
Voltage-dependent calcium channel gamma-7 subunit0101
Voltage-dependent L-type calcium channel subunit beta-10101
Voltage-dependent calcium channel gamma-1 subunit0101
Voltage-dependent L-type calcium channel subunit beta-20101
Voltage-dependent R-type calcium channel subunit alpha-1E0101
Voltage-dependent calcium channel subunit alpha-2/delta-40101
Voltage-dependent calcium channel subunit alpha-2/delta-30101
Voltage-dependent calcium channel gamma-8 subunit0101
Voltage-dependent calcium channel gamma-6 subunit0101
Voltage-dependent calcium channel subunit alpha-2/delta-20202
Voltage-dependent calcium channel gamma-4 subunit0101
Voltage-dependent calcium channel gamma-5 subunit0101
Voltage-dependent calcium channel gamma-2 subunit0101
Sodium/iodide cotransporter0101
Estrogen receptor0011
Estrogen receptor beta0011
CDGSH iron-sulfur domain-containing protein 10202
Nociceptin receptor0134
Nociceptin receptor0225
Sodium- and chloride-dependent betaine transporter0101
FAD-linked sulfhydryl oxidase ALR0001
Chain A, Adipocyte Lipid-binding Protein0011
Chain A, MUSCLE FATTY ACID BINDING PROTEIN0011
Chain A, MUSCLE FATTY ACID BINDING PROTEIN0011
Chain A, MUSCLE FATTY ACID BINDING PROTEIN0011
Chain A, BCL-2-RELATED PROTEIN A10011
putative potassium channel subunit0011
bcl-2-like protein 11 isoform 10011
Sterol O-acyltransferase 10101
Fatty acid-binding protein, liver0011
DNA topoisomerase 10202
Protein kinase C alpha type0001
Tyrosine-protein phosphatase non-receptor type 10204
Sterol O-acyltransferase 10101
Peroxisome proliferator-activated receptor delta0001
Peroxisome proliferator-activated receptor alpha1012
Mcl-10101
pyruvate kinase PKM isoform a1001
Sodium/potassium-transporting ATPase subunit alpha-1 0202
Sodium/potassium-transporting ATPase subunit beta-10202
Sodium/potassium-transporting ATPase subunit alpha-30202
Sodium/potassium-transporting ATPase subunit beta-20202
Bifunctional cytochrome P450/NADPH--P450 reductase0011
Potassium-transporting ATPase subunit beta0101
Potassium-transporting ATPase alpha chain 10101
Bombesin receptor subtype-30011
UDP-glucuronosyltransferase 2B10 0202
Fatty acid synthase0404
Sodium/potassium-transporting ATPase subunit alpha-20202
Potassium-transporting ATPase alpha chain 20001
Sodium/potassium-transporting ATPase subunit beta-30202
Sodium/potassium-transporting ATPase subunit gamma0202
WD repeat-containing protein 50101
Glutathione S-transferase omega-10101
Histone-lysine N-methyltransferase 2A0101
Sodium/potassium-transporting ATPase subunit alpha-40202
Cytosolic endo-beta-N-acetylglucosaminidase0101
Interleukin-6 receptor subunit alpha0101
Thyrotropin-releasing hormone receptor0101
Glycine receptor subunit alpha-40101
Leukotriene B4 receptor 10101
polyadenylate-binding protein 10101
bcl-2-related protein A10101
Oxytocin receptor0011
Beta-secretase 10123
interferon gamma precursor0001
Somatostatin receptor type 10101
Arylacetamide deacetylase0001
Arylacetamide deacetylase0001
Arylacetamide deacetylase0001
Chain A, Penicillin Amidohydrolase0101
Chain B, Penicillin Amidohydrolase0101
Chain A, Penicillin Amidohydrolase0101
Chain B, Penicillin Amidohydrolase0101
Chain A, Penicillin Amidohydrolase0101
Chain B, Penicillin Amidohydrolase0101
Chain A, Penicillin Amidohydrolase0101
Chain B, Penicillin Amidohydrolase0101
Chain A, Penicillin Amidohydrolase0101
Chain B, Penicillin Amidohydrolase0101
Chain A, Penicillin Amidohydrolase0101
Chain B, Penicillin Amidohydrolase0101
Chain A, Penicillin Amidohydrolase0101
Chain B, Penicillin Amidohydrolase0101
Chain A, Lysozyme0011
Chain A, Lysozyme0011
Chain A, Lysozyme0011
Chain A, Lysozyme0011
Chain A, Ferritin light chain0022
Chain A, Ferritin light chain0022
Chain A, Ferritin light chain0022
Chain A, Ferritin light chain0022
Chain A, Ferritin light chain0022
Chain A, Ferritin light chain0022
Chain A, Ferritin light chain0022
Endolysin0011
Alpha-1B adrenergic receptor0202
Dihydrofolate reductase 0101
Muscarinic acetylcholine receptor DM10202
Muscarinic acetylcholine receptor M50101
Muscarinic acetylcholine receptor M30101
Muscarinic acetylcholine receptor M20101
Taste receptor type 2 member 310011
Taste receptor type 2 member 600011
Sodium/potassium/calcium exchanger 40112
Taste receptor type 2 member 140012
Taste receptor type 2 member 130011
Taste receptor type 2 member 90011
Taste receptor type 2 member 40011
Sodium/potassium/calcium exchanger 20112
luciferase0001
Glucocorticoid receptor0112
Glucocorticoid receptor0011
Mineralocorticoid receptor 0213
Glutamine synthetase0011
Neuromedin-K receptor0011
Cholecystokinin receptor type A0112
Sodium/bile acid cotransporter0101
Nuclear receptor subfamily 2 group E member 10022
Pyridoxal kinase0001
Lysine-specific demethylase 4E0101
runt-related transcription factor 1 isoform AML1b1001
core-binding factor subunit beta isoform 21001
Advanced glycosylation end product-specific receptor0011
Beta-lactamase 0101
Advanced glycosylation end product-specific receptor0011
Neutrophil cytosol factor 10112
5-hydroxytryptamine receptor 1D0303
5-hydroxytryptamine receptor 2A0101
nuclear factor NF-kappa-B p105 subunit isoform 11001
Quinolone resistance protein NorA0102
Chromaffin granule amine transporter0101
Synaptic vesicular amine transporter0101
Synaptic vesicular amine transporter0213
Synaptic vesicular amine transporter0101
Prostaglandin G/H synthase 20101
Cytochrome c oxidase subunit 10101
Calpain-2 catalytic subunit0101
Transporter0101
Sodium-dependent serotonin transporter0101
Estrogen receptor beta0001
Inhibitor of nuclear factor kappa-B kinase subunit beta0001
5'-AMP-activated protein kinase subunit beta-20001
Polymerase acidic protein0011
Stromelysin-10112
Tyrosine-protein phosphatase YopH0101
High mobility group protein B10011
Prolyl 4-hydroxylase subunit alpha-10101
Estrogen receptor0001
Cystathionine gamma-lyase0101
5'-AMP-activated protein kinase subunit gamma-10001
5'-AMP-activated protein kinase catalytic subunit alpha-20001
Xanthine dehydrogenase/oxidase0101
5'-AMP-activated protein kinase catalytic subunit alpha-10001
Ubiquitin-like domain-containing CTD phosphatase 10101
5'-AMP-activated protein kinase subunit gamma-30001
5'-AMP-activated protein kinase subunit gamma-20001
5'-AMP-activated protein kinase subunit beta-10001
Pyruvate kinase PKM0011
Neutral amino acid transporter A0101
Neutral amino acid transporter B(0)0101
Amino acid transporter0101
Free fatty acid receptor 30011
Enoyl-[acyl-carrier-protein] reductase [NADH]0001
Protein-arginine deiminase type-40202
Neuromedin-K receptor0011
Substance-K receptor0112
Neuromedin-K receptor0112
Substance-K receptor0101
Substance-K receptor0101
Growth hormone secretagogue receptor type 10011
Carboxypeptidase M0101
5-hydroxytryptamine receptor 1B0101
5-hydroxytryptamine receptor 1B0101
Neuromedin-U receptor 20011
Adenylate kinase isoenzyme 10001
Adenylate kinase 2, mitochondrial0001
Capsid protein 0011
DNA gyrase subunit B0101
Transcriptional activator protein LuxR0101
Dipeptidyl peptidase 40101
DNA gyrase subunit A0101
C-C chemokine receptor type 50202
Chain X, Thyroid hormone receptor beta-10022
Chain X, Thyroid hormone receptor beta-10022
Transthyretin0103
Proliferating cell nuclear antigen0202
Malate dehydrogenase, mitochondrial0101
Solute carrier organic anion transporter family member 1A20002
Solute carrier organic anion transporter family member 4C10102
Monocarboxylate transporter 80001
Solute carrier organic anion transporter family member 1C10001
Chain A, Carbonic anhydrase 10101
Carbonic anhydrase 20101
procathepsin L isoform 1 preproprotein0101
Solute carrier organic anion transporter family member 4C10001
Solute carrier organic anion transporter family member 4A10001
Solute carrier organic anion transporter family member 1C10101
Vif0101
Tat0101
Indoleamine 2,3-dioxygenase 10203
Strictosidine synthase0001
Cathepsin K0101
Trace amine-associated receptor 10022
Chain A, Trp Rna-binding Attenuation Protein0011
Chain K, Trp Rna-binding Attenuation Protein0011
Chain B, tryptophanyl-tRNA synthetase0011
Chain C, Tryptophanyl-tRNA synthetase II0011
Alkaline phosphatase, tissue-nonspecific isozyme0101
Intestinal-type alkaline phosphatase0101
Tryptophan 2,3-dioxygenase0102
Tryprostatin B synthase0001
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase0011
Phospholipase A-2-activating protein0101
guanine nucleotide-binding protein subunit alpha-150112
D(3) dopamine receptor isoform e1001
trace amine-associated receptor 10112
Dopamine beta-hydroxylase 0001
Trace amine-associated receptor 10011
Chain A, CHORISMATE MUTASE0101
Chain A, TYROSYL-tRNA SYNTHETASE0011
Tubulin--tyrosine ligase0101
Cocaine esterase0101
Aldo-keto reductase family 1 member A10101
Aldo-keto reductase family 1 member A10101
Aldo-keto reductase family 1 member A10101
Aldo-keto reductase family 1 member B70101
Glycoprotein0101
Catechol O-methyltransferase0101
Potassium voltage-gated channel subfamily A member 30101
glycogen synthase kinase-3 beta isoform 10011
Adenosylhomocysteinase0101
Adenosine deaminase 0001
RNA-directed RNA polymerase 0112
Proprotein convertase subtilisin/kexin type 70101
Vitamin K epoxide reductase complex subunit 1-like protein 10101
Vitamin K epoxide reductase complex subunit 10101
Protease 0101
Vitamin K epoxide reductase complex subunit 1-like protein 10101
Vitamin K epoxide reductase complex subunit 1 0202
Amine oxidase [flavin-containing] B0101
Amine oxidase [flavin-containing]0101
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]